Next Article in Journal
Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells
Previous Article in Journal
CD45 and Basigin (CD147) Are Functional Ligands for Galectin-8 on Human Leukocytes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ca2+ Signaling in Striated Muscle Cells During Intracellular Acidosis

1
Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania
2
Center of Physiology, Pathophysiology and Biophysics, Paracelsus Medical University, 90419 Nuremberg, Germany
3
Department of Biophysics and Cellular Biotechnology, University of Medicine and Pharmacy “Carol Davila” Bucharest, 050474 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Biomolecules 2025, 15(9), 1244; https://doi.org/10.3390/biom15091244
Submission received: 24 July 2025 / Revised: 13 August 2025 / Accepted: 25 August 2025 / Published: 28 August 2025
(This article belongs to the Special Issue The Role of Calcium Signaling in Cardiac and Skeletal Muscle)

Abstract

The cytosolic pH (pHi) of mammalian cells is tightly maintained at values ~7.2. Cytoplasmic acidosis (pHi < 6.8) occurs when the intracellular proton concentration ([H+]i) exceeds the buffering capacity of the cytosol and transport processes to extrude protons are exhausted. During intracellular acidosis, the contractility of cardiac and skeletal muscle cells is strongly reduced, often at sufficient Ca2+ levels. A contraction of striated muscle is achieved when the intracellular calcium (Ca2+) concentration rises above resting levels. The amplitude and kinetics of Ca2+ signals are controlled by Ca2+ handling proteins and force is generated if Ca2+ ions interact with contractile filaments of the sarcomere. Some aspects of this phenomenon, such as the biochemical origin of excessive protons in working muscle cells and molecular interactions of protons with Ca2+ handling proteins or contractile filaments, are not yet fully understood. This review summarizes our current understanding of how striated muscle cells handle Ca2+ and H+ and how a rise in [H+]i may interfere with Ca2+ signaling in the working skeletal muscle (fatigue) or during ischemic events in cardiac muscle. Finally, we briefly address experimental strategies to measure Ca2+ signaling at different pH values with fluorescent probes and highlight their limitations.

1. Introduction

The concentration of free protons ([H+]) in aqueous solutions is low and commonly expressed on a logarithmic scale as pH = −log [H+] [1,2]. In mammalian cells, extracellular pH (pHo) is rigorously maintained between 7.3–7.4 [3,4,5], whereas intracellular pH (pHi) ranges between 7.0–7.2 (skeletal muscle cells and cardiac myocytes) [6,7]. When transient metabolic changes in free [H+] occur, pHi is kept constant by means of buffering. In biological solutions, weak acids or bases, such as phosphate groups and side chains of amino acids of proteins, serve as proton buffers. In addition, cells employ transport systems for acids and bases, such as proton pumps and transporters or bicarbonate shuttles to fine-tune pHi on the long-term range [4]. There is a modulatory role of pHi on Ca2+ signaling in striated muscle cells [8,9,10,11] and non-excitable cells [12]. Cells use Ca2+ ions as secondary messengers to regulate different cellular functions, including contraction of smooth and striated muscle [13,14,15]. Ca2+ signaling occurs when the low, resting Ca2+ concentration (~100 nM) suddenly increases to values up to 1–2 µM and Ca2+ sensor proteins integrate the information encoded by Ca2+ signals, such as amplitude, frequency and duration, with cellular functions. Endogenous Ca2+ sensing proteins relevant for striated muscle cell function are calmodulin (CaM), which controls enzymes and ion channels [16] and troponin, which controls muscle contraction (see below) [17,18]. The intracellular Ca2+ concentration ([Ca2+]CYT) increases due to activity of plasmalemmal ion channels mediating Ca2+ influx and/or intracellular Ca2+ release channels, which liberate Ca2+ from intracellular stores, such as the endoplasmic reticulum (ER) or the sarcoplasmic reticulum (SR) in muscle cells. Ca2+ signals that control muscle contraction are brief and reversible (“Ca2+ transient”) and resting Ca2+ levels are established via removal of Ca2+ ions from the cytosol by Ca2+ pumps, such as the plasma membrane Ca2+ ATPase (PMCA, Ca2+ extrusion), the sarcoplasmic/endoplasmic Ca2+ ATPase (SERCA, store-refilling) and plasmalemmal Ca2+ exchangers [15,19,20,21]. In addition to Ca2+ release and removal mechanisms, intracellular Ca2+ signals are shaped by reversible binding of Ca2+ ions to intracellular proteins serving as Ca2+ buffers [22]. Ca2+ signaling is affected by pHi via two mechanisms: First, H+ and Ca2+ compete for identical binding sites at protein buffers. This has the consequence that protonation of a buffer will increase its Kd for Ca2+ [23] and a rise in [H+] (a fall in pH) will unavoidably increase the free [Ca2+] and vice versa [3]. Second, the protonation of Ca2+ handling proteins at secondary sites [24] may allosterically alter their function to transport Ca2+ [25].
Acidosis is the fall of pH below physiological values [26] and is recognized as a clinical parameter when plasma pH is <7.35 (acidemia) due to metabolic or respiratory disturbances [27]. Respiratory acidosis can cause a rapid fall in pHo due to an extracellular buildup of CO2. Because CO2 is highly diffusible across lipid bilayers, a rise in extracellular CO2 causes an increase of the cell’s acid load, which lowers pHi [4,28]. Intracellular acidosis is defined as a fall of pHi < 6.8 and it occurs when there are more free cytosolic protons than buffers can bind and transport processes can remove from the cytoplasm [4]. Acidosis is frequently observed under physiological conditions due to metabolic processes in working muscle or pathologically in ischemic tissue under hypoxic conditions or during inflammation. It is worth noting that any fall in pHo during extracellular acidosis will directly cause an accompanying fall in pHi since protons can easily cross the plasma membrane via diffusion or transport processes [3]. Therefore, a direct relation between low pHo values and intracellular acidosis has been demonstrated for cardiac, skeletal and smooth muscle cells [29,30]. This review will focus on the effects of intracellular acidosis on striated muscle Ca2+ handling and contraction. Intracellular acidosis causes a remarkable reduction in striated muscle contractility, which is the ability of the muscle to generate force. As part of this special issue, our review aims to introduce the Ca2+ signaling events that lead to contraction in striated muscle cells and to provide an overview of the most important cellular mechanisms that contribute to the reduction in contractility during acidosis in skeletal and cardiac cells. We will also briefly address optical techniques to assess Ca2+ signaling and pHi with fluorescent probes in living cells to study those processes.

2. Excitation–Contraction Coupling (ECC) in Striated Muscle Cells

The signaling process that mediates contraction of striated muscle cells is called excitation-contraction coupling (ECC) [31,32,33]. The term summarizes a chain of signaling events in which an electrical signal of the plasma membrane, an action potential (AP), is converted into mechanical contraction via intracellular Ca2+ release (Figure 1). APs propagate into the depth of muscle cells via invaginations of the plasma membrane named T-tubules (Figure 1, 1). In striated muscle cells, excitation of the T-tubule is coupled with a mechanism that releases Ca2+ from the SR (electrical coupling, Figure 1, 2). In skeletal muscle cells, electrical coupling is achieved by activation of the dihydropyridine receptor (DHPR), which is directly coupled to a Ca2+ release channels of the sarcoplasmic reticulum (SR), the ryanodine receptors type 1 (RyR1s, Figure 1, box 1, 2a) [34]. In cardiac cells, electrical coupling involves the L-type Ca2+ channel (LTCC), which mediates Ca2+ influx. Ca2+ ions diffuse to adjacent SR membranes and open the Ca2+-gated, cardiac ryanodine receptor type 2 (RyR2, Figure 1, box 1, 2b) [35,36]. Opening of either type of RyR causes rapid release of Ca2+ from the SR into the cytosol down its concentration gradient (Figure 1, 3), which is converted into mechanical contraction at the sarcomere (Figure 1, 4). The kinetics, amplitude and duration of this intracellular Ca2+ elevation define the speed, strength and duration of muscle contractions, respectively [37].
The molecular steps controlling Ca2+-dependent contractions are identical for cardiac and skeletal muscle cells: a rise in intracellular Ca2+ induces cross-bride formation between actin and myosin, a process that is regulated by the Ca2+-sensitive troponin–tropomyosin complex [38]. At low [Ca2+]CYT, troponin masks the myosin interaction sites on the actin molecule and cross-bridge formation is prevented. At high [Ca2+]CYT, Ca2+ binds to the regulatory protein troponin and induces a conformational change of the troponin–tropomyosin complex, which liberates myosin binding sites on the actin molecule (Figure 1, box 2) [39]. Cross-bridge formation will shorten sarcomeres, which are the contractile units of striated muscle cells (Figure 1, 4) [17,40,41]. The force a striated muscle can generate depends on the sum of all cross-bridges, a process with steep Ca2+ dependence [42,43]. The second important molecule that regulates the cross-bridge cycle is ATP, which binds to myosin [44]. The affinity of myosin molecules for actin is low when ATP is bound to the myosin head (loose cross bridges) and high if ATP is hydrolyzed and ADP is bound to myosin (Figure 1, box 2). The hydrolysis rate of ATP and the ATP-to-ADP exchange rate at myosin heads determine the speed of new cross-bridge formations (i.e., the speed of contraction) [45,46,47].
The muscle relaxes when [Ca2+]CYT falls back to resting levels. This is controlled by Ca2+-dependent inactivation of RyRs at high cytosolic Ca2+ concentrations [35,36,48] and by activation of Ca2+ transport mechanisms that remove Ca2+ from the cytosol. The major transport processes in striated muscle cells involve SERCA at the SR (Figure 1, 5) and the plasmalemmal sodium calcium exchanger (NCX) [33,37,49] (Figure 1, 6). The latter uses the Na+ gradient across the plasma membrane for Ca2+ extrusion, which is generated by the Na+/K+-ATPase (Figure 1, 7). For skeletal muscle cells there is experimental evidence that refilling of the SR with Ca2+ ions is supported by Ca2+-influx via store-operated Ca2+ entry (SOCE, Figure 1, 9) [50]. In contrast, cardiac SOCE generates only locally restricted Ca2+ signals that do not seem to contribute to contractile Ca2+ signaling [51]. Established functional roles for cardiac SOCE are the regulation of pacemaker activity of the sinoatrial node [52] and activation of gene transcription processes associated with cardiac hypertrophy and heart failure [53,54].
Additionally, mitochondria can store Ca2+ ions and thus may affect [Ca2+]CYT and ECC. Any elevation in cytoplasmic Ca2+ may cause an uptake of Ca2+ into mitochondria via Ca2+ diffusion through the mitochondrial uniporter (Figure 1, 8) [55]. The exact [Ca2+] within the mitochondrial matrix is cell type-specific. In resting striated muscle cells, it is equal or close to [Ca2+]CYT [56]. In rat cardiac myocytes, expression of a mitochondria-specific Ca2+ biosensor revealed that resting mitochondrial Ca2+ levels were between 70 nM and 100 nM and the mitochondrial Ca2+ concentration increased with each cytosolic Ca2+ transient when ECC was evoked by electrical stimulation of the cells, an effect that was attributed to diffusion of Ca2+ from the cytosol into mitochondria [57]. The effect of mitochondrial Ca2+ uptake on [Ca2+]CYT is more pronounced in cardiac cells, in which mitochondria occupy ~30% of the cell volume [58,59]. Whether mitochondrial Ca2+ buffering is relevant in skeletal muscle cells is a matter of debate [60]. One limiting factor might be that mitochondria occupy only a small volume (~2% to 6%) of skeletal muscle cells [61]. Functional roles of mitochondrial Ca2+ uptake/buffering include shaping of Ca2+ transients, fine-tuning of CICR at ER/mitochondrial contact sites [62] and providing a feedback signal that couples mitochondrial ATP production to its cytoplasmic demand during cell contractions [58,59].
Taking this complexity of ECC into consideration, there are many molecular steps that can be modified by acidosis. We will summarize next how a fall in pHi below normal values can alter ECC, Ca2+ signaling and Ca2+ buffering. This is relevant for the contractile function of striated muscle, which is severely depressed by intracellular acidosis occurring in physiological and pathological conditions.

3. Mechanisms Inducing Intracellular Acidosis in Striated Muscle Cells

Skeletal muscle. Fatigue is the inability of the muscle to generate sustained force or power during repetitive contractions [63,64]. Within this period, the speed of individual muscle contractions slows down and maximal force is reduced. Fatigue is well pronounced in fast muscle fibers and less or not at all pronounced in slower muscle fibers [65]. Initially it was assumed that fatigue is the simple result of excessive consumption of energy (ATP) during heavy workloads of the muscle [66]. In this scenario, fatigue occurs whenever muscle fibers consume ATP faster than it can be supplied by metabolic processes. While this mechanism may contribute to fatigue in fast-twitching muscle fibers, some studies indicated that intracellular ATP levels are not likely to fall to a level that may compromise contraction in most muscle types [67] and muscle fibers displayed fatigue at constant ATP levels [68]. Instead, there is evidence that skeletal muscle fatigue is the result of an accumulation of protons and Pi in the working muscle. Acidosis has been associated with fatigue and occurs in a reversible manner during intense exercise [69], in which pHi can fall from ~7.0 (at rest) to ~6.4 (fatigued) in human skeletal muscle [7]. During longer periods of exercise, ATP synthesis depends on glycolysis that generates pyruvate, which either fuels ATP generation in mitochondria (via the tricarboxylic acid cycle) or which is converted to lactate by the enzyme lactate dehydrogenase (LDH) in the cytosol when mitochondrial uptake is saturated [70]. Since it was discovered that the lactate concentration rises in working skeletal muscles [71], the term “lactic acidosis” has been associated with fatigue. The underlying concept implies that accumulation of lactic acid or lactate due to increased glycolysis rates will cause intracellular acidification [7,72]. Others have argued that the biochemistry of skeletal muscle cells would not be compatible with this concept. Some counter arguments include the following: (1) The final product of glycolysis in the cytosol is pyruvate. Mitochondria import pyruvate and consume protons to supply ATP in working muscle, which limits pyruvate accumulation in the cytosol [73,74]. Furthermore, when mitochondrial import is exhausted, excessive pyruvate in the cytosol is converted by LDH to lactate, but not to lactic acid (which could lower pHi). Lactate, in turn, stimulates monocarboxylate transporters (MCTs), which are symporters that transport lactate and protons out of the cell (Figure 2) [75]. Due to this transport mechanism, the plasma concentration of lactate can rise about five times to ~8 mM during intense exercise [76]. Extracellular lactate can enter neighboring muscle cells or cells of other tissues via MCTs, which operate bidirectionally, where it fuels ATP synthesis following its conversion back into pyruvate [77]. The conclusion is that mitochondrial metabolism and MCT-mediated transport will limit the accumulation of lactate and protons, so that the fall in pHi cannot be caused by glycolysis alone. (2) Based on experiments using skinned skeletal muscle fibers, there is no direct evidence that lactate impairs contractility, even at high concentrations [70]. It has been suggested that the high rates of ATP hydrolysis at myosin molecules during heavy exercise would generate excessive protons in the cytoplasm [70,78,79,80]. Irrespective of the biochemical origin of those protons, significant acidification of skeletal muscle cells occurs during long periods of intense exercise and intramuscular pHi was reported to fall to values ≤ 6.4 in fatigued skeletal muscle [7]. Considering all this, mechanisms inducing intracellular acidosis are not restricted to ATP deficiency, lactate accumulation or high glycolysis rates, but also caused by direct accumulation of protons stemming from alternative biochemical processes. It is likely that mechanisms other than ATP hydrolysis may contribute to proton accumulation, such as release of protons from buffers or using protons as counter ions for Ca2+ transportation into organelles. Those mechanisms are not well investigated yet (discussed in Section 5), and they may contribute to local rather than global changes in pH.
Cardiac muscle. Intracellular acidosis does not occur during normal activity of the heart. Metabolic changes that occur during physiological heartbeats do not cause acidification [81], probably due to the large buffering capacity of cardiac myocytes for protons (20–90 mM/pH unit) [31]. However, severe intracellular acidosis occurs in cardiac cells during pathologies that alter the acid–base homeostasis and lead to extracellular acidification, due to respiratory or metabolic disturbances, sleep apnea and ischemia. Respiratory acidosis is characterized by a buildup of extracellular CO2, which induces a rapid fall in pHi [4]. This is caused via diffusion of CO2 across the plasma membrane and/or via cellular uptake of protons from the extracellular space. The latter is evenly effective, because the plasma membrane has a large conductance for protons [82] and the electrochemical driving force for protons favors proton influx [4]. Consequently, there is a direct relationship between the fall of pHo and a corresponding fall of pHi in muscle cells [30,83]. Cardiac ischemia lowers pHi significantly: in diabetic cardiac myocytes, pHi values as low as 6.0 have been observed during ischemic episodes, an effect that was reversible once normal oxygenation was established [84]. When pHi falls this much, the cardiac contractility is markedly reduced [85]. Thus, in contrast to skeletal muscle, the mechanisms leading to intracellular acidification of cardiac myocytes are rather caused by extracellular pH changes than by intrinsic metabolic changes in pHi.

4. Effect of Low pHi on Striated Muscle Contractility

Skeletal muscle. High-intensity exercise affects ECC via mechanisms that are pH-independent and pH-dependent. In intact muscle tissue, there is an accumulation of extracellular K+ within T-tubules due to K+ efflux during APs, which depolarizes the tubules. ECC and Ca2+ release was shown to be efficient up to [K+]o~10 mM but strongly impaired when [K+]o reached concentrations of 14–15 mM [86]. Such large K+ concentrations were observed locally, within the small volume of T-Tubules [87]. The resulting membrane depolarization limits the spread of excitation within the T-tubule and delays the recovery of the DHPR voltage sensor from inactivation, both of which render electrical coupling less efficient [88]. Intracellular acidosis has several consequences on ECC. (1) Inhibition of RyR1 by protons reduces Ca2+ release (Figure 2, 1). Single channel recordings demonstrated maximal RyR1 channel open probabilities Po at pH = 7.4, but almost complete closure of the RYR1 at pH = 6.5 [36]. This limits the amount of Ca2+ that is available for contractions and can reduce the peak force per individual twitch by more than 30% in skinned skeletal muscle fibers [89]. (2) There are multiple effects on proteins of the contractile apparatus (Figure 2, 2): first, protonation reduces the Ca2+-sensitivity of purified troponin C [90] and approximately three-times more Ca2+ is required to form all cross-bridges required for 50% of force generation (pCa50) in skinned muscle fibers [91]. Furthermore, the interaction of troponin C and troponin I, which defines the speed of cross-bridge formation, is less efficient, as shown in myofibril preparations [92]. Protonation of myosin reduces its affinity for actin, which affects the total number of cross-bridges and reduces the muscle tension by about 20% and 45%, depending on the type of skinned muscle fiber (fast or slow twitch) studied [93,94]. Importantly, those negative inotropic effects persisted even at saturating Ca2+ concentrations [95], suggesting that pH-related modifications of contractile proteins dominate the negative inotropic effect. (3) High rates of ATP hydrolysis in the working muscle result in accumulation of ADP, Pi and H+ within the sarcomere (Figure 2, 3). Protons and Pi act synergistically and have a large negative effect on contractility: Pi reaches peak concentrations between 15 mM and 30 mM in working skeletal muscle [96]. Raising Pi to 30 mM induced a large shift in the force–pCa relationship to the right for both slow- and fast-type, skinned muscle fibers [97], which means that more Ca2+ is required to generate force. This suggests that, like protons, Pi alone can strongly depress the generation of force. Furthermore, an accumulation of Pi stabilizes the ADP + Pi-bound conformation of myosin, which slows down the transition from ADP-to-ATP-bound form. This reduces the velocity of cross-bridge formation and impairs the formation of new cross-bridges. In addition, it reduces the force that previously formed cross-bridges had already developed [97,98]. Moreover, Pi can react with protons to its diprotonated form, which seems to have a larger negative inotropic effect than Pi or protons alone when applied to skinned fibers [99]. In combination, all those molecular events reduce the efficiency of Ca2+ ions to activate the cross-bridge cycle and/or reduce the force that existing cross-bridges can produce. (4) A rise in intracellular protons reduces the pump function of SERCA (Figure 2, 4). When SERCA function was measured in vesicles obtained from skeletal muscle SR preparations, a change in pH from 7.0 to 6.0 reduced maximal pump rates (Vmax) by ~50%, an effect that was accompanied by a reduction in the pump’s Ca2+-affinity [100]. This is consistent with the observed decline in SR Ca2+-content and Ca2+ transient amplitude during acidosis in skeletal muscle fibers [101,102]. (5) In sarcolemmal vesicle preparations, the transport rate of NCX, which is stimulated by intracellular Ca2+, depends on pHi: transport by NCX was stimulated at pH = 9, but inhibited at pH = 6 [103]. This inhibition occurred allosterically following protonation of two histidine residues (H124, H165) within the transporter molecule, which are not located within the Ca2+ binding domains [104]. Any reduction in NCX transport rate may cause an elevation of [Ca2+]CYT (Figure 2, 5). Because the cardiac isoform NCX1 has higher maximal Ca2+ transport rates than the skeletal isoform NCX3 [33,105], its inhibition by protons may cause a larger rise in [Ca2+]CYT in cardiac cells than in skeletal muscle cells [106,107]. (6) Ca2+ currents underlying SOCE (Figure 2, 7) were dependent on pHi. Ca2+ release-activated Ca2+ currents (ICRAC) recorded at pHi = 6.3 were reduced by more than 50% as compared to control currents recorded at pHi = 7.3 [108]. Furthermore, ICRAC was strongly dependent on pHo, which falls during ischemia or tissue inflammation. A reduction in pHo from 7.4 to 6.3 almost completely abolished ICRAC. The dependencies of SOCE currents on internal and external pH have been attributed to protonation of several key residues distributed throughout the Orai molecule [109]. SOCE activity contributes to SR Ca2+ load in intact skeletal muscle fibers [50], suggesting that any reduction in SOCE-mediated Ca2+ influx may reduce the filling status of the SR in skeletal muscle cells during acidosis.
The mechanisms described above collectively contribute to exercise-induced or physiological fatigue at low pHi values in skeletal muscle. It is important to note that contractility experiments are often conducted using single muscle fibers (intact or skinned) to precisely control experimental parameters. Can one extrapolate those results to the situation of intact muscles in vivo? Performance measurements in muscles from healthy subjects showed that exercise-induced, intracellular acidosis (pHi~6.5) reduced the total force, speed of contraction and peak power [110] to similar degrees than reported for single fibers. However, a comparison between different muscle types proves difficult because the degree of fatigue appears to be fiber type-specific: whereas intracellular acidosis exerted a pronounced negative inotropic effect in fast twitching fibers, it had little effect on slow twitching muscle fibers [110]. Therefore, not every type of muscle may display the same sensitivity to intracellular pH changes. Moreover, in intact muscle multiple metabolic changes occur at the same time: for example, mitochondria produce large amounts of reactive oxygen species (ROS) [111] and the increasing temperature in working muscle also seems to impair muscle performance [112]. ROS are known to modify the function of Ca2+ handling proteins, which impairs cellular Ca2+ handling [113,114]. The negative effect of ROS on skeletal muscle function is even more evident when the native ability of the cells to buffer ROS is reduced, as in metabolic disorders or during inflammation [115]. Thus, it may be difficult to estimate the relative contribution of each metabolite to fatigue in vivo (see Discussion below). The development of novel animal models for exercise-induced fatigue may help to better understand long-term molecular changes underlying skeletal muscle fatigue on systemic and organ levels in future studies [116]. If pathological acidemia occurs, the contractility of skeletal muscle can be further impaired by additional long-term structural and functional changes in the muscle that involve degradation of proteins and impaired energy supply due to mitochondrial dysfunction [117].
Cardiac muscle. Many of those effects described above apply to cardiac myocytes as well. There are, however, some notable differences: At normal pHo, there is no net accumulation of K+ in T-tubules during contractions with high frequencies, because K+ removal via Na+/K+-ATPase pump activity is more efficient in cardiac myocytes than in skeletal muscle cells [88]. Unlike in the working skeletal muscle, in which glycolysis is the main source for ATP, the majority (>90%) of cardiac ATP stems from aerobic processes [118] and the main source for intracellular acidification is CO2 released by mitochondria. CO2 can leave the cell by diffusion across the membrane, or it reacts with H2O to bicarbonate and protons, a reaction that is catalyzed by CAs [119]. It is assumed that under physiological conditions, the rate of protons generated by hydration of CO2 is in balance with transport rates of proton export mechanisms [120] (see below). However, significant intracellular acidosis causes a strong depression in the contractility of cardiac Purkinje fibers [121]. It is frequently observed during cardiac ischemia, which is characterized by a fall in pHo and pHi, a reduced rate of ATP synthesis, negative inotropy [122,123,124] and, surprisingly, by a rise in [Ca2+]CYT [123]. Intracellular acidosis has the following effects on cardiac ECC: (1) in isolated ventricular myocytes, protons affected the gating mechanism of L-type currents, and the amplitude of currents were 2.5 times smaller at pHi = 6.2 as compared to pHi = 7.2 [125], which reduces the efficiency of electrical coupling (Figure 1, box 1, 2b) [126]. In addition, low pHi prevents PKA-mediated phosphorylation of LTCCs following β-adrenergic stimulation, which normally yields to larger Ca2+ currents and a gain in ECC efficiency [127]. The same mechanism blunts the compensatory positive inotropic effect that sympathetic nerve stimulation normally has on the human heart once the pump function turns weaker [128]. (2) Lipid bilayer experiments revealed an inhibition of RyR2s by cytoplasmic protons [129]. In intact and skinned cardiac myocyte preparations, the same effect caused less Ca2+ release from the SR per AP (Figure 2, 1), reflected by systolic Ca2+ transients with amplitudes that can drop by 50% at the beginning of acidosis [130,131,132]. However, during prolonged periods of acidosis the Ca2+ transient amplitudes recover [130], which is caused by an increase in diastolic [Ca2+]CYT and subsequent increase in SR Ca2+ load [35,123]. (3) Experiments using either papillary muscle or cardiac Purkinje fibers revealed that the increase in diastolic [Ca2+]CYT is partially caused by release of Ca2+ ions from internal buffers due to competition of H+ and Ca2+ ions for common binding sites (discussed in Section 5) [133,134] and by the following modifications of ion transport processes: the sodium–proton exchanger (NHE) is stimulated by intracellular protons (Figure 2, 11) [135] and NHE activation will lead to accumulation of internal Na+. Simultaneous inhibition of the Na+/K+-ATPase (Figure 2, 6), which would normally remove excessive Na+, further contributes to the accumulation of internal Na+ at low pHi [136]. This reduces the Na+ gradient across the membrane that provides energy for other Na+-dependent transporters, as shown in inside-out patch-clamp experiments on ventricular myocytes [137]. Na+ accumulation affects Ca2+ extrusion by NCX: at low, physiological Na+ concentrations, allosteric inhibition of NCX by cytoplasmic Na+ fine-tunes the transport rate of NCX in forward mode and thus, regulates cardiac excitability and beat-to-beat Ca2+ changes in isolated myocytes and in intact hearts [138]. However, at higher internal Na+ concentrations, NCX will start to remove excessive Na+ at the cost of transporting Ca2+ into the cell (reverse mode of NCX, discussed below) [103]. In addition to its modulation by Na+, NCX itself is directly inhibited by protons as described above (Figure 2, 5) [104], an effect that is sensitized by intracellular Na+ when assessed in excised patches from ventricular sarcolemma [139]. In ventricular myocytes, the reduced transport rates of NCX in its forward mode caused a net elevation of diastolic [Ca2+]CYT, which stimulates SERCA and increases SR Ca2+ load by more than 100 µM [123]. The stimulatory effect of Ca2+ on SERCA seems to compensate for the three-times slower transport rates (Vmax) induced by protonation of cardiac SERCA alone, which was observed in experiments using SR vesicle preparations (Figure 2, 4) [100]. Following cardiac ischemia, the reverse mode of NCX causes severe damage of cardiac tissue. Due to the low pHo during the ischemic period, the transport rate of NHE is reduced. Once reperfusion occurs, pHo recovers quickly and NHE begins to rapidly transport protons out of the cell. This causes fast accumulation of Na+ (Figure 2, 11) and, in turn, rapid Ca2+ influx as NCX tries to remove the excessive Na+ in its reverse operation mode. In hearts from animal models and humans, this unusual large influx of Ca2+ via NCX represents a substrate for cardiac arrhythmias and causes more damage of the myocardium (reperfusion injury) [140,141]. A recent study suggests that inhibition of cardiac NCX1 by protons may contribute to Ca2+ overload and reperfusion injury in the same way as the Na+-driven regulation: during experimentally-induced acidosis (pHi = 6.5), ventricular myocytes from genetically modified mice expressing a proton-insensitive mutant of NCX1 (H165A) did not show increases in Ca2+ transient amplitudes, suggesting that NCX was not inhibited and hearts from transgenic mice displayed reduced tissue damage following an ischemia–reperfusion protocol in comparison to wild-type mice [142]. This suggests, in turn, that the modulations of NCX by Na+ and H+ may induce Ca2+ overload in a synergistic fashion. (4) Like in skeletal muscle, in isolated papillary muscle the negative inotropic effect of intracellular acidosis is dominated by the reduced Ca2+ sensitivity of the cardiac contractile apparatus (pCa50 is shifted by +0.1 unit/per fall of 0.1 pH unit) [124]. In experiments using intact myocytes, contractility remained depressed during acidosis, although the systolic Ca2+-transient amplitudes increased above control levels [130]. (5) A rise in [H+]CYT induces proton uptake into mitochondria via different transporter systems in exchange for Ca2+, Na+ or K+ ions (Figure 2, 8) [59]. Measurements using isolated mitochondria from ventricular myocytes showed that acidification of mitochondria reduces the electrochemical gradient that the mitochondrial uniporter uses for Ca2+ transport and limits mitochondrial Ca2+ uptake [143]. This effect may add to the elevation of [Ca2+]CYT during acidosis. Interestingly, changes in pHi in cardiac myocytes are not homogenous, as one would assume due to the high diffusion speed of protons in aqueous solutions [144], but may rather occur as pH gradients: intracellular pH measurements in isolated ventricular myocytes revealed that there is a subcellular heterogeneity of pH due to local interaction of protons with intracellular buffers, which slows down the diffusion speed of protons [145,146,147,148]. Consequently, pH gradients may locally enhance those inhibitory effects that protons have on Ca2+ handling proteins. If systemic acidemia cannot be treated, e.g., during chronic sepsis or kidney failure, then the pump function of the heart is impaired via two mechanisms. First, metabolic acidosis causes a fall in pHo, which reduces organ perfusion, causing tissue hypoxia [149]. Second, intracellular acidosis depresses the contractile function of cardiac myocytes by the mechanisms described above. On the level of the human heart, this translated into reduced left ventricular contractility and reduced cardiac output in patients with systemic acidemia (pHo < 7.28) as compared to a cohort of patients with normal blood pH (pHo > 7.28). Among the functional parameters that were affected by intracellular acidosis were stroke volume (reduced by ~40%) and ejection fraction (reduced by ~30%) [150]. Both parameters directly determine cardiac output. Thus, alterations of cardiac pump functions due to intracellular acidosis may contribute to the poor survival rate that is associated with chronic acidemia [151].
If intracellular acidosis is reversible, excessive protons are removed from the cytosol of ventricular myocytes by the following mechanisms: activation of the voltage-gated proton channel HV1 (Figure 2, 9; see Section 7) [152]; export via MCT (Figure 2, 10); Na+/H+-exchange by NHE (Figure 2, 11) and reaction with the cytosolic CO2/bicarbonate buffer system [153]. In the mammalian heart, intracellular bicarbonate is provided by Na+/bicarbonate cotransport (NBC, Figure 2, 12) [154] and by the CA reaction, which generates bicarbonate by hydration of CO2 stemming from mitochondrial respiration [119,155]. Bicarbonate leaves the cell by Cl/bicarbonate anion exchange (AE, Figure 2, 13) [156]. In striated muscle, at low pHi values, CAs catalyze the reverse reaction of protons with bicarbonate to H2O and CO2 that leaves the cell by diffusion (Figure 2, 14) [157]. CAs are not restricted to the cytoplasm and have been localized to different compartments, such as plasma membrane, mitochondria and the SR, where they regulate local pH [158]. Extracellular CAs in capillaries and erythrocytes reverse this reaction and hydrate CO2 to bicarbonate and protons. The interplay between intracellular and extracellular CAs is important to maintain the CO2 gradient and diffusion of CO2 across the plasma membrane [159]. The CO2/bicarbonate system contributes to ~20% of the total proton buffer capacity in skeletal muscle [160] and has a slightly larger buffer capacity in cardiac myocytes [161]. The importance of the CO2/bicarbonate buffering system for cardiac function was directly demonstrated by the observation that the contractility of isolated murine myocytes and whole-heart preparations declined over time in the absence of a bicarbonate buffer due to an accumulation of intracellular protons, an effect that reversed when the same preparation was bathed in a CO2/bicarbonate buffer and pHi was normalized [156]. Despite contributing to buffering of protons, a recent study demonstrated that bicarbonate may emerge as an important signaling molecule that stimulates mitochondrial ATP production in isolated, contracting cardiac myocytes via a mechanism that is independent from mitochondrial Ca2+ [162]. Dysregulation of the CO2/bicarbonate buffer system or proton transport processes have been implicated in skeletal muscle or cardiac pathologies. For example, upregulation of CAs represents a biomarker for cardiac ischemia and heart failure in humans [163,164]. During cardiac hypertrophy, upregulation of NBCs to rectify pHi caused Na+ accumulation and Ca2+ overload via NCX [165].
Chronic fatigue syndrome is characterized by a high sympathetic tone, to which skeletal muscles respond with secretion of vasodilators, including protons, to improve muscle perfusion (“sympathetic escape” [166]). One factor that contributes to this mechanism is an upregulation of NHE that may induce Na+ overload and Ca2+-overload, which further deteriorates the contractile function of an already weak muscle [167]. In line with this, the pharmacological inhibition of NHE prevented muscle degeneration in a mouse model of Duchenne’s muscle dystrophy [168]. Based on results from several animal studies, an inhibition of NHE1 has been suggested as a potential novel treatment option to reduce tissue hypoxia and cardiac damage during metabolic acidosis in humans [169]. Despite affecting Ca2+ handling proteins, a fall in pHi will also alter the properties of Ca2+ buffers and Ca2+ storing organelles, which we will discuss below.

5. Effect of Low pHi on Ca2+ Buffers and Ca2+-Storing Organelles

In most cells Ca2+ ions are bound to ~99% to intracellular buffers [23]. To give an example, calculations for cardiac myocytes suggest that a change in free cytosolic Ca2+ from resting levels of 100 nM to ~1 μM during systole will require the net mobilization of as much as 100 μM Ca2+ from internal stores in the presence of internal buffers [31]. The simplest interference between protons and Ca2+ ions in the cytoplasm is their competition for the same binding sites at intracellular buffers [25]. The most relevant cytosolic Ca2+ buffer in type II (fast twitch) skeletal muscle fibers is the protein parvalbumin [170]. Parvalbumin is considered a slow buffer because it binds both Ca2+ and Mg2+ thus its Ca2+ buffering properties depend on competition with Mg2+ [171,172]. Considering this, Ca2+ buffering by parvalbumin does not limit the rapid rising phase and amplitude of Ca2+ transients during single twitches, but affects the decay of the transient and thus, the relaxation time of skeletal muscle [173]. In contrast, there is no relevant role for parvalbumin in type I (slow twitch) muscle fibers due to their slow relaxation [170]. In heart tissue, parvalbumin expression was species-specific [174], with low expression levels in human and larger animals and higher expression in small animals, according to the relaxation speed [175]. The most relevant Ca2+ buffers in cardiac cells are the Ca2+ binding sites of troponin C [176] and SERCA [177]. Computer models suggest that simple binding (buffering) of Ca2+ ions to troponin C and SERCA, followed by active transport of Ca2+ into the SR shape Ca2+ transients in the decay phase of the Ca2+ signal [177]. Because protonation lowers the Kd of buffers for Ca2+, it is plausible that intracellular acidification will liberate a substantial amount of Ca2+ into the cytosol, which may affect [Ca2+]CYT during acidosis [178]. The effect that acidosis lowers the Ca2+ buffer capacity of parvalbumin has been shown in dorsal root ganglia neurons [179]; however this effect has not been established for striated muscle. For cardiac troponin C protonation decreases its affinity for Ca2+ [180], which should result in liberation of Ca2+ from contractile filaments during acidosis and impaired contractility.
Mitochondria are organelles that can buffer transient changes in cytoplasmic Ca2+ via Ca2+ diffusion through the mitochondrial uniporter (Figure 1, 5) [181,182] and can release mitochondrial Ca2+ into the cytosol by Na+/Ca2+ exchange [181,183]. In cardiac muscle, it is a matter of debate whether mitochondrial Ca2+ uptake occurs fast on a beat-to-beat basis or in an integrative manner as slow increase over time, dependent on the frequency of contractions [184]. It has been suggested that mitochondrial Ca2+ uptake may contribute to feedback mechanisms that couple cytoplasmic ATP demand with mitochondrial ATP production by activating Ca2+-sensitive enzymes that control the tricarboxylic acid cycle [55,185,186]. At the same time mitochondria maintain the proton gradient across the inner mitochondrial membrane by pumping out the protons via complexes I, III and IV of the respiratory chain, to provide, in combination with the mitochondrial membrane potential, the energy for ATP synthesis [187]. There is some experimental evidence that cytosolic pHi and mitochondrial Ca2+ signaling can interfere: acidification of the cytoplasm was accompanied by proton uptake via Na+/H+ exchanger, K+/H+-exchanger and Ca2+/H+ exchanger and proton leak [188,189,190], leading to acidification of mitochondria, which inhibited mitochondrial Ca2+ uptake by the mitochondrial uniporter in mitochondria isolated from cardiac cells [143] (Figure 2, 7). In isolated, electrically paced cardiac myocytes, oscillatory changes in pHi (“pH transients”) displayed kinetics that resembled the beat-to-beat changes in cytosolic Ca2+ transients [191]. The authors suggested as an underlying mechanism that Ca2+ uptake by mitochondria will induce simultaneous release of protons into the cytosol, which caused the observed fluctuations in pHi. Those fluctuations were small (±0.1 pH units) and it remains to be established if they contribute to intracellular acidosis.
Lysosomes are traditionally seen as organelles involved in protein turnover and degradation of biomaterial (“waste removal”) [192,193] but not recognized as cellular compartments involved in Ca2+ signaling, even though they display high proton and Ca2+ contents [20,194]. Interference of protons with Ca2+ ions occurs during transport processes across the lysosomal membrane. Lysosomes maintain a low luminal pH ~4.5 to create a pH optimum for acid hydrolases [195]. In addition, they contain a considerably large amount of luminal Ca2+ (~500 μM) [194], which is partially released during vesicle fusion processes [196]. It has been suggested that lysosomes contribute to Ca2+ buffering in skeletal muscle cells and cardiac myocytes [197]. Lysosomal V-ATPases pump protons from the cytosol into the lumen of lysosomes [198]. This adds positive charges to an organelle with a very small lumen and to maintain the electrochemical gradient across the lysosomal membrane, any proton influx must be compensated either by import of anions, such as Cl, or by export of cations, including Ca2+, via lysosomal ion channels and exchangers [199,200]. Even though the overall volume of lysosomes per cell volume is very small (~3%) [194], local release of lysosomal Ca2+ via type 2 two-pore channels has been implicated in triggering larger cytoplasmic Ca2+ release events from intracellular Ca2+ stores via CICR by modifying IP3-Rs in non-excitable cells [201] or cardiac RyR2 signaling in atrial and ventricular myocytes [202]. In skeletal muscle cells, lysosomes form contact sites with the SR, mitochondria and the nuclear membrane, but the effector proteins of lysosomal signaling at those sites are not well defined [203].
Another organelle that can contribute to transport of protons into the cytosol is the SR. The pump cycle of Ca2+-ATPases requires charge compensation: whenever SERCA pumps Ca2+ ions into the SR, the added charge is compensated by antiport of two protons to the cytosol for each Ca2+ ion that enters the SR lumen [204]. Whether acidification affects [Ca2+]CYT and ECC by Ca2+ release from buffers or cell organelles in striated muscle cells has not been addressed yet.
This complexity of local and global variations of pH requires the use of appropriate methods that are sensitive and specific to measure Ca2+ and pH in different cellular compartments with sufficient temporal and spatial resolution. The next chapter will give a short overview of established and recently developed optical tools that can be used to measure Ca2+ and pH in living cells.

6. Optical Methods to Measure Ca2+CYT and pHi in Living Cells

To study how changes in pH will affect Ca2+ signaling, fluorescent indicators have been used to directly monitor changes in pH or [Ca2+] in living cells. Fluorescent Ca2+ indicators are available as chemical compounds (Ca2+ dyes) that are loaded into cells or as genetically encoded biosensors based on fluorescent proteins, which are expressed by the cells. For both types of indicators, intensity-based and ratiometric variants are available [205,206]. There are advantages for the choice of either type for experiments: chemical indicators are well-established [207], require less experimental intervention and offer a wide range of affinities for Ca2+ ions [208]. The major advantage of genetically encoded probes is the possibility to target them to cell organelles, which allows simultaneous Ca2+ measurements in the cytosol and in organelles, such as ER or mitochondria [209]. In general, sensors with high affinity for Ca2+ are used in the cytosol, whereas sensors with low affinity for Ca2+ can be used to measure Ca2+ in organelles with high Ca2+ content, such as the SR or lysosomes. Popular organelle-specific Ca2+ biosensors based on fluorescent proteins are the indicators of the GECO family [209,210,211,212]. During experiments at constant pH, changes in fluorescence of the Ca2+ indicator reflect changes in [Ca2+]. However, the assessment of [Ca2+]CYT during dynamic changes of pHi is challenging, because most Ca2+ indicators are pH-sensitive: for example, in situ calibrations demonstrated that the Kd for Ca2+ of the widely used indicator fura-2 was approximately two-times lower at pH = 7.2 than at pH = 6.6, which means that a considerably larger Ca2+ concentration is required to cause a similar change in the emission ratio of fura-2 [30]. Being proteins, genetically encoded Ca2+ sensors bind protons as well and the intensity of emitted fluorescence depends on pH, a phenomenon that is either caused by direct quenching of the fluorophore [213] and/or due to competition of protons with Ca2+ ions at Ca2+ binding domains of those sensors. Thus, careful pH-calibration of Ca2+ sensors may be required for fluorescence measurements at different pHi values. On the other hand, the generation of fluorescence intensity/pH curves established specific pKa values for each type of fluorescent protein used in biosensors [214]. This allows one to design fluorescent biosensors for specific applications, such as Ca2+ sensors that are bright enough at the very low pH values in lysosomes [215]. Comprehensive reviews on chemical Ca2+ indicators and Ca2+ biosensors are given by Paredes and colleagues [208] and by Mank and Griesbeck [216], respectively.
There is also a wide range of chemical indicators or protein-based biosensors for the optical assessment of pHi available. One simple way to measure cytoplasmic pH is the use of enhanced YFP (eYFP, pKa = 7.1), which is pH-sensitive and gets dimmer when protonated [217]. As for Ca2+ measurements, using targeted fluorescent proteins allows measurements of pH changes within cell organelles [217]. An example of a chemical dye to measure pHi is the widely used compound BCECF (pKa~7.0), which is a dual-excitation, single emission ratiometric indicator suitable for intracellular pH changes from pH = 6.5–7.5 [218]. Newer pH-sensitive fluorescent proteins include red-shifted variants of fluorescent proteins or ratiometric sensors and are engineered with enhanced quantum yield, improved dynamic range and tailored to match the specific pH values of organelles, such as the ER, the Golgi apparatus, mitochondria or lysosomes. A recent overview on protein-based pH-biosensors is given by Li and colleagues [214] and chemical pH indicators are described in detail by Han and Burgess [218]. For some experiments it may be useful to monitor pHi and [Ca2+]CYT simultaneously. This can be achieved by using combinations of Ca2+ indicators and pH indicators with different spectral properties, such as the Ca2+ indicators fura-2 or indo-1 in combination with the pH indicator SNARF, which does not show a high affinity for Ca2+ ions [219,220]. The advantage of this approach is that one can distinguish the kinetics of Ca2+ changes from the kinetics of pH changes in real time. These tools are necessary to quantify the degree of acidosis during physiological activity and pathological states of striated muscle cells and to correlate pH changes with functional changes. Transgenic animal models expressing genetically encoded biosensors can be used for long-term studies of acidosis in striated muscle cells.

7. Discussion and Outlook

Intracellular acidosis is a strong inductor of negative inotropy in striated muscle cells. We have introduced general mechanisms on how protons may alter the function of Ca2+ handling proteins and the contractile apparatus. Many molecular aspects of this phenomenon are still controversially discussed for the two types of striated muscle cells. Studying the effects of protons on Ca2+ signaling can be challenging because properties of Ca2+ indicators are sensitive to pH, which requires careful interpretation of acquired data. Moreover, data on skeletal muscle contractility seem to be highly sensitive to experimental conditions: some results obtained from experiments using isolated muscle cells (skinned or intact fibers), such as the degree of negative inotropy that individual metabolites will induce, could not be confirmed in intact skeletal muscle preparations [221,222]. Storage of tissue samples for future experiments may also affect the contractile properties of muscle fibers: a recent paper demonstrated that storage in glycerol, a commonly used freezing agent, affected the passive stiffness of skeletal fibers [223]. Furthermore, it seems critical whether results were obtained at room temperature, which is common for fiber studies, or at body temperature, which is used for muscle preparations or studies in vivo [224]. This has led to some skepticism about how well single cell data may be extrapolated to the situation in intact muscle [221,222], thus further investigations will be required to address ischemia in the whole organ. During cardiac ischemia, excessive production of ROS affects cardiac excitability and adds to the negative inotropic effect as many Ca2+ handling proteins are redox-sensitive [113,114]. Experimentally, it may be difficult to separate proton-induced effects from ROS-mediated alterations of Ca2+ handling proteins in intact organ preparations.
An interesting outlook for future studies lies in alternative signaling pathways that cells can use to sense changes in pH: many cell types that experience sudden intracellular acidification can rectify intracellular acidosis by activation of proton channels [82]. Proton channel currents have been identified in skeletal myotubes [225] and adult skeletal muscle cells [226], but their physiological role is not well defined. The expression of proton channel mRNA in cardiac tissue has been described for multiple species [227], and there is some indication for upregulation of cardiac proton channel transcripts during heart failure [228]. Recently, functional currents of the voltage-gated proton channel HV1 were recorded in adult canine ventricular myocytes and pharmacological blockade of this channel in the absence of NHE activity lowered pHi from 7.1 to 6.13 in beating myocytes [152]. Thus, HV1 contributes to the regulation of pHi in ventricular myocytes when [H+]CYT rises (Figure 2, 10), an alternative pathway to proton exchange by NHE [229,230]. The advantage of a voltage-gated proton channel, compared to a transporter like NHE, lies in its exclusive ability to conduct protons out of the cell, driven by the electrochemical gradient. In all primary mammalian cells measured to date, it does not permit proton influx [231]. Thus, during acidification, it requires no additional energy while counteracting the drop in cytosolic pH. This is particularly beneficial for excitable cells, as the channel expels protons from the cytosol during depolarization, which also serves as the gating mechanism for the channel. Depolarization typically occurs just before a rise in energy demand in muscle cells, when metabolically generated protons begin to accumulate. The mechanism underlying this unique biophysical property—functioning as a proton “overpressure valve”, exclusively conducting protons out of the cell—is still under investigation [232]. Nonetheless, voltage-gated proton channels have been identified in various mammalian cell types [233]. Another notable feature is the absolute selectivity for protons, with no other ions conducted [234]. A frequently overlooked capability of the voltage-gated proton channel is its ability to sense both intracellular and extracellular pH, effectively making it a cellular “pH meter.” In line with the topic of this review, it is worth noting that the first scientists to voltage-clamp this channel also investigated the relationship between intracellular calcium and pH in excitable cells [235].
Other membrane proteins that cells use to sense pHo include Ca2+-conducting cation channels (ASIC- and TRP channels) [236], and the rather novel, but small class of proton-sensing, G-protein-coupled receptors (GPCRs) [237]. Some of those receptors couple to heterotrimeric Gq proteins and activate phospholipase C (PLC), which controls intracellular Ca2+ signals by activating IP3-mediated Ca2+ release from the SR [15]. The PLC-IP3-Ca2+ signaling axis controls gene transcription [238,239] and could potentially contribute to long-term adaptation processes of muscle cells to acidification. In skeletal muscle cells, the functional roles of conventional GPCRs or proton-sensing GPCRs are not well investigated, but there is evidence that some orphan receptors could belong to the class of proton-sensing GPCRs [240]. In the heart transcripts of GPR68, a proton-sensing GPCR which activates PLC, have been identified in neonatal ventricular myocytes [236] and adult tissue. Thus, proton-sensing GPCRs have been suggested as novel drug targets to treat ischemic heart diseases [241].

8. Conclusions

In conclusion, although the functional consequences of intracellular acidosis on the contractility of striated muscle cells are well established, the molecular aspects of proton biochemistry underlying acidosis remain unclear. There are interesting, unexplored signaling pathways that could link acidification during ischemia with Ca2+ signaling and gene transcription in striated muscle cells. The continuous development of fluorescent biosensors to assess Ca2+ and pHi in living cells will prove useful to investigate those aspects in the future.

Author Contributions

Conceptualization: A.R., F.P. and B.M.; writing, review and editing: A.R., F.P. and B.M.; visualization: A.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The figures of this article were created in BioRender.com: Rinne, A. (2025); https://BioRender.com/itrywxc (accessed on 5 July 2025).

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ADPAdenosine diphosphate
AE(Cl/bicarbonate) anion exchanger
ATPAdenosine triphosphate
ASICAcid-sensing ion channel
BCECF2″,7″-Bis-(2-carboxyethyl)-5-(and-6-) carboxyfluorescein
Ca2+Calcium ion
[Ca2+]CYTIntracellular (cytosolic) Ca2+ concentration
CO2Carbon dioxide
CRACCa2+ release-activated current
CICRCa2+-induced Ca2+ release
DHPRDihydropyridine receptor
ECCExcitation-contraction coupling
EREndoplasmic reticulum
GECOGenetically encoded calcium indicator for optical imaging
GqGq alpha subunit of heterotrimeric G proteins
GPCRG-protein-coupled receptor
GPR68G-protein-coupled receptor 68
H+Proton
[H+]CYTIntracellular (cytosolic) proton concentration
HV1Hydrogen voltage-gated channel 1
IP3Inositol trisphosphate
IP3RIP3 receptor
KdDissociation constant
LTCCL-type Ca2+ channel
MCTMonocarboxylate transporter
mTMitochondrial transport
mUMitochondrial uniporter
nAChRNicotinic acetylcholine receptor
[NA+]CYTIntracellular (cytosolic) sodium concentration
NBCSodium-bicarbonate cotransporter
NCXSodium-calcium exchanger
NHESodium-proton exchanger
pCa50Negative logarithm of the Ca2+ concentration at 50% force development
PCO2Partial pressure of CO2
pHNegative logarithm of the proton concentration [H+]
pHiIntracellular (cytosolic) pH
pHoExtracellular pH
PiInorganic phosphate
PIP2Phosphatidylinositol bisphosphate
pKaNegative logarithm of the acid dissociation constant Ka
PKAProtein kinase A
PLCPhospholipase C
ROSReactive oxygen species
RyRRyanodine receptor
SERCASarcoplasmic/endoplasmic Ca2+ ATPase
SNARFSeminaphtorhodafluor
SOCEStore-operated Ca2+ entry
SRSarcoplasmic reticulum
TRPTransient receptor potential
V-ATPaseVacuolar-type ATPase
VGSCVoltage-gated sodium channel
YFPYellow fluorescent protein

References

  1. Myers, R.J. One-hundred years of pH. J. Chem. Educ. 2010, 87, 30–32. [Google Scholar] [CrossRef]
  2. Sørensen, S.P.L. Über die Messung und die Bedeutung der Wasserstoffionenkonzentration bei enzymatischen Prozessen. Biochem. Z. 1909, 21, 131. [Google Scholar]
  3. Putnam, R.W. 22—Intracellular pH regulation. In Cell Physiology Source Book, 3rd ed.; Sperelakis, N., Ed.; Academic Press: San Diego, CA, USA, 2001; pp. 357–372. [Google Scholar]
  4. Boron, W.F. Regulation of intracellular pH. Adv. Physiol. Educ. 2004, 28, 160–179. [Google Scholar] [CrossRef]
  5. Casey, J.R.; Grinstein, S.; Orlowski, J. Sensors and regulators of intracellular pH. Nat. Rev. Mol. Cell Biol. 2010, 11, 50–61. [Google Scholar] [CrossRef] [PubMed]
  6. Ellis, D.; Thomas, R. Direct measurement of the intracellular pH of mammalian cardiac muscle. J. Physiol. 1976, 262, 755–771. [Google Scholar] [CrossRef] [PubMed]
  7. Fitts, R.H. Cellular mechanisms of muscle fatigue. Physiol. Rev. 1994, 74, 49–94. [Google Scholar] [CrossRef] [PubMed]
  8. Baker, A.J.; Brandes, R.; Weiner, M.W. Effects of intracellular acidosis on Ca2+ activation, contraction, and relaxation of frog skeletal muscle. Am. J. Physiol. Cell Physiol. 1995, 268, C55–C63. [Google Scholar] [CrossRef]
  9. Westerblad, H.; Allen, D.G. The influence of intracellular pH on contraction, relaxation and [Ca2+]i in intact single fibres from mouse muscle. J. Physiol. 1993, 466, 611–628. [Google Scholar] [CrossRef]
  10. Williamson, J.R.; Safer, B.; Rich, T.; Schaffer, S.; Kobayashi, K. Effects of acidosis on myocardial contractility and metabolism. Acta Medica Scand. 1976, 199, 95–112. [Google Scholar] [CrossRef]
  11. Williamson, J.R.; Schaffer, S.W.; Ford, C.; Safer, B. Contribution of tissue acidosis to ischemic injury in the perfused rat heart. Circulation 1976, 53, I3–I14. [Google Scholar]
  12. Gonzalez, A.; Pariente, J.A.; Salido, G.M.; Camello, P.J. Intracellular pH and calcium signalling in rat pancreatic acinar cells. Pflügers Arch. 1997, 434, 609–614. [Google Scholar] [CrossRef]
  13. Kuo, I.Y.; Ehrlich, B.E. Signaling in muscle contraction. Cold Spring Harb. Perspect. Biol. 2015, 7, a006023. [Google Scholar] [CrossRef]
  14. Hill-Eubanks, D.C.; Werner, M.E.; Heppner, T.J.; Nelson, M.T. Calcium signaling in smooth muscle. Cold Spring Harb. Perspect. Biol. 2011, 3, a004549. [Google Scholar] [CrossRef]
  15. Clapham, D.E. Calcium signaling. Cell 2007, 131, 1047–1058. [Google Scholar] [CrossRef]
  16. Yang, C.-F.; Tsai, W.-C. Calmodulin: The switch button of calcium signaling. Tzu Chi Med. J. 2022, 34, 15–22. [Google Scholar] [CrossRef] [PubMed]
  17. Katrukha, I.A. Human cardiac troponin complex. Structure and functions. Biochemistry. Biokhimiia 2013, 78, 1447–1465. [Google Scholar] [CrossRef]
  18. Palmer, S.; Kentish, J.C. The role of troponin C in modulating the Ca2+ sensitivity of mammalian skinned cardiac and skeletal muscle fibres. J. Physiol. 1994, 480, 45–60. [Google Scholar] [CrossRef]
  19. Putney, J.W. Capacitative calcium entry: From concept to molecules. Immunol. Rev. 2009, 231, 10–22. [Google Scholar] [CrossRef]
  20. Bootman, M.D. Calcium signaling. Cold Spring Harb. Perspect. Biol. 2012, 4, a011171. [Google Scholar] [CrossRef] [PubMed]
  21. Berridge, M.J. Calcium microdomains: Organization and function. Cell Calcium 2006, 40, 405–412. [Google Scholar] [CrossRef] [PubMed]
  22. Schwaller, B. Cytosolic Ca2+ buffers are inherently Ca2+ signal modulators. Cold Spring Harb. Perspect. Biol. 2020, 12, a035543. [Google Scholar] [CrossRef] [PubMed]
  23. Eisner, D.; Neher, E.; Taschenberger, H.; Smith, G. Physiology of intracellular calcium buffering. Physiol. Rev. 2023, 103, 2767–2845. [Google Scholar] [CrossRef]
  24. Schönichen, A.; Webb, B.A.; Jacobson, M.P.; Barber, D.L. Considering protonation as a posttranslational modification regulating protein structure and function. Annu. Rev. Biophys. 2013, 42, 289–314. [Google Scholar] [CrossRef]
  25. Molinari, G.; Nervo, E. Role of protons in calcium signaling. Biochem. J. 2021, 478, 895–910. [Google Scholar] [CrossRef]
  26. Owen, J.A.; Robson, J.S. The nomenclature of acid-base balance. Scott. Med. J. 1956, 1, 294–296. [Google Scholar] [CrossRef]
  27. Adrogué, H.J.; Gennari, F.J.; Galla, J.H.; Madias, N.E. Assessing acid–base disorders. Kidney Int. 2009, 76, 1239–1247. [Google Scholar] [CrossRef]
  28. Roos, A.; Boron, W.F. Intracellular pH. Physiol. Rev. 1981, 61, 296–434. [Google Scholar] [CrossRef]
  29. Vanheel, B.; de Hemptinne, A.; Leusen, I. Influence of surface pH on intracellular pH regulation in cardiac and skeletal muscle. Am. J. Physiol. Cell Physiol. 1986, 250, C748–C760. [Google Scholar] [CrossRef] [PubMed]
  30. Peng, H.-L.; Jensen, P.E.; Nilsson, H.; Aalkjær, C. Effect of acidosis on tension and [Ca2+]i in rat cerebral arteries: Is there a role for membrane potential? Am. J. Physiol.Heart Circ. Physiol. 1998, 274, H655–H662. [Google Scholar] [CrossRef] [PubMed]
  31. Bers, D.M. Excitation-Contraction Coupling. In Excitation-Contraction Coupling and Cardiac Contractile Force; Developments in Cardiovascular Medicine; Springer: Dordrecht, The Netherlands, 2001; Volume 237, pp. 203–244. [Google Scholar]
  32. Bers, D.M. Cardiac excitation–contraction coupling. Nature 2002, 415, 198–205. [Google Scholar] [CrossRef]
  33. Calderón, J.C.; Bolaños, P.; Caputo, C. The excitation–contraction coupling mechanism in skeletal muscle. Biophys. Rev. 2014, 6, 133–160. [Google Scholar] [CrossRef]
  34. Anderson, K.; Meissner, G. T-tubule depolarization-induced SR Ca2+ release is controlled by dihydropyridine receptor- and Ca2+-dependent mechanisms in cell homogenates from rabbit skeletal muscle. J. Gen. Physiol. 1995, 105, 363–383. [Google Scholar] [CrossRef] [PubMed]
  35. Xu, L.; Mann, G.; Meissner, G. Regulation of cardiac Ca2+ release channel (ryanodine receptor) by Ca2+, H+, Mg2+, and adenine nucleotides under normal and simulated ischemic conditions. Circ. Res. 1996, 79, 1100–1109. [Google Scholar] [CrossRef] [PubMed]
  36. Ma, J.; Fill, M.; Knudson, C.M.; Campbell, K.P.; Coronado, R. Ryanodine receptor of skeletal muscle is a gap junction-type channel. Science 1988, 242, 99–102. [Google Scholar] [CrossRef]
  37. Dirksen, R.T.; Eisner, D.A.; Ríos, E.; Sipido, K.R. Excitation—Contraction coupling in cardiac, skeletal, and smooth muscle. J. Gen. Physiol. 2022, 154, e202213244. [Google Scholar] [CrossRef]
  38. Craig, R.; Padrón, R. Molecular structure of the sarcomere. Myology 2004, 3, 129–144. [Google Scholar]
  39. Hitchcock-DeGregori, S.E.; Barua, B. Tropomyosin Structure, Function, and Interactions: A Dynamic Regulator. In Fibrous Proteins: Structures and Mechanisms; Parry, D., Squire, J., Eds.; Springer: Cham, Switzerland, 2017; Volume 82, pp. 253–284. [Google Scholar]
  40. Sevrieva, I.R.; Kampourakis, T.; Irving, M. Structural changes in troponin during activation of skeletal and heart muscle determined in situ by polarised fluorescence. Biophys. Rev. 2024, 16, 753–772. [Google Scholar] [CrossRef] [PubMed]
  41. Herzog, W.; Schappacher-Tilp, G. Molecular mechanisms of muscle contraction: A historical perspective. J. Biomech. 2023, 155, 111659. [Google Scholar] [CrossRef]
  42. Huxley, H.E. The crossbridge mechanism of muscular contraction and its implications. J. Exp. Biol. 1985, 115, 17–30. [Google Scholar] [CrossRef]
  43. Fuchs, F.; Smith, S.H. Calcium, cross-bridges, and the frank-starling relationship. Physiology 2001, 16, 5–10. [Google Scholar] [CrossRef]
  44. Sweeney, H.L.; Houdusse, A. The motor mechanism of myosin v: Insights for muscle contraction. Philos. Trans. R. Soc. B Biol. Sci. 2004, 359, 1829. [Google Scholar]
  45. Rayment, I.; Holden, H.M.; Whittaker, M.; Yohn, C.B.; Lorenz, M.; Holmes, K.C.; Milligan, R.A. Structure of the actin-myosin complex and its implications for muscle contraction. Science 1993, 261, 58–65. [Google Scholar] [CrossRef]
  46. Capitanio, M.; Canepari, M.; Cacciafesta, P.; Lombardi, V.; Cicchi, R.; Maffei, M.; Pavone, F.S.; Bottinelli, R. Two independent mechanical events in the interaction cycle of skeletal muscle myosin with actin. Proc. Natl. Acad. Sci. USA 2006, 103, 87–92. [Google Scholar] [CrossRef]
  47. Baker, J.E.; Brosseau, C.; Joel, P.B.; Warshaw, D.M. The biochemical kinetics underlying actin movement generated by one and many skeletal muscle myosin molecules. Biophys. J. 2002, 82, 2134–2147. [Google Scholar] [CrossRef]
  48. Lanner, J.T.; Georgiou, D.K.; Joshi, A.D.; Hamilton, S.L. Ryanodine receptors: Structure, expression, molecular details, and function in calcium release. Cold Spring Harb. Perspect. Biol. 2010, 2, a003996. [Google Scholar] [CrossRef]
  49. Bolaños, P.; Calderón, J.C. Excitation-contraction coupling in mammalian skeletal muscle: Blending old and last-decade research. Front. Physiol. 2022, 13, 989796. [Google Scholar] [CrossRef] [PubMed]
  50. Sztretye, M.; Geyer, N.; Vincze, J.; Al-Gaadi, D.; Oláh, T.; Szentesi, P.; Kis, G.; Antal, M.; Balatoni, I.; Csernoch, L.; et al. SOCE is important for maintaining sarcoplasmic calcium content and release in skeletal muscle fibers. Biophys. J. 2017, 113, 2496–2507. [Google Scholar] [CrossRef] [PubMed]
  51. Bonilla, I.M.; Belevych, A.E.; Baine, S.; Stepanov, A.; Mezache, L.; Bodnar, T.; Liu, B.; Volpe, P.; Priori, S.; Weisleder, N.; et al. Enhancement of cardiac store operated calcium entry (SOCE) within novel intercalated disk microdomains in arrhythmic disease. Sci. Rep. 2019, 9, 10179. [Google Scholar] [CrossRef]
  52. Zhang, H.; Sun, A.Y.; Kim, J.J.; Graham, V.; Finch, E.A.; Nepliouev, I.; Zhao, G.; Li, T.; Lederer, W.; Stiber, J.A. Stim1–Ca2+ signaling modulates automaticity of the mouse sinoatrial node. Proc. Natl. Acad. Sci. USA 2015, 112, E5618–E5627. [Google Scholar] [CrossRef]
  53. Hulot, J.-S.; Fauconnier, J.; Ramanujam, D.; Chaanine, A.; Aubart, F.; Sassi, Y.; Merkle, S.; Cazorla, O.; Ouillé, A.; Dupuis, M. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation 2011, 124, 796–805. [Google Scholar] [CrossRef]
  54. Correll, R.N.; Goonasekera, S.A.; van Berlo, J.H.; Burr, A.R.; Accornero, F.; Zhang, H.; Makarewich, C.A.; York, A.J.; Sargent, M.A.; Chen, X. Stim1 elevation in the heart results in aberrant Ca2+ handling and cardiomyopathy. J. Mol. Cell. Cardiol. 2015, 87, 38–47. [Google Scholar] [CrossRef]
  55. Perocchi, F.; Gohil, V.M.; Girgis, H.S.; Bao, X.R.; McCombs, J.E.; Palmer, A.E.; Mootha, V.K. MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake. Nature 2010, 467, 291–296. [Google Scholar] [CrossRef] [PubMed]
  56. Fernandez-Sanz, C.; De la Fuente, S.; Sheu, S.S. Mitochondrial Ca2+ concentrations in live cells: Quantification methods and discrepancies. FEBS Lett. 2019, 593, 1528–1541. [Google Scholar] [CrossRef]
  57. Wüst, R.C.; Helmes, M.; Martin, J.L.; van der Wardt, T.J.; Musters, R.J.; van der Velden, J.; Stienen, G.J. Rapid frequency-dependent changes in free mitochondrial calcium concentration in rat cardiac myocytes. J. Physiol. 2017, 595, 2001–2019. [Google Scholar] [CrossRef]
  58. Rossini, M.; Filadi, R. Sarcoplasmic reticulum-mitochondria kissing in cardiomyocytes: Ca2+, ATP, and undisclosed secrets. Front. Cell Dev. Biol. 2020, 8, 532. [Google Scholar] [CrossRef]
  59. Poburko, D.; Demaurex, N. Regulation of the mitochondrial proton gradient by cytosolic Ca2+ signals. Pflügers Arch. Eur. J. Physiol. 2012, 464, 19–26. [Google Scholar] [CrossRef] [PubMed]
  60. Reggiani, C.; Marcucci, L. A controversial issue: Can mitochondria modulate cytosolic calcium and contraction of skeletal muscle fibers? J. Gen. Physiol. 2022, 154, e202213167. [Google Scholar]
  61. Pesta, D. Mitochondrial density in skeletal and cardiac muscle. Mitochondrion 2024, 75, 101838. [Google Scholar] [CrossRef]
  62. D’Angelo, D.; Vecellio Reane, D.; Raffaello, A. Neither too much nor too little: Mitochondrial calcium concentration as a balance between physiological and pathological conditions. Front. Mol. Biosci. 2023, 10, 1336416. [Google Scholar] [CrossRef]
  63. Kent-Braun, J.A.; Fitts, R.H.; Christie, A. Skeletal muscle fatigue. Compr. Physiol. 2012, 2, 997–1044. [Google Scholar] [CrossRef] [PubMed]
  64. Lännergren, J.; Westerblad, H. Force decline due to fatigue and intracellular acidification in isolated fibres from mouse skeletal muscle. J. Physiol. 1991, 434, 307–322. [Google Scholar] [CrossRef]
  65. Allen, D.G.; Lamb, G.D.; Westerblad, H. Skeletal muscle fatigue: Cellular mechanisms. Physiol. Rev. 2008, 88, 287–332. [Google Scholar] [CrossRef]
  66. Pollack, G.H. The cross-bridge theory. Physiol. Rev. 1983, 63, 1049–1113. [Google Scholar] [CrossRef]
  67. Sundberg, C.W.; Fitts, R.H. Bioenergetic basis of skeletal muscle fatigue. Curr. Opin. Physiol. 2019, 10, 118–127. [Google Scholar] [CrossRef]
  68. Debold, E.P.; Beck, S.E.; Warshaw, D.M. Effect of low pH on single skeletal muscle myosin mechanics and kinetics. Am. J. Physiol. Cell Physiol. 2008, 295, C173–C179. [Google Scholar] [CrossRef] [PubMed]
  69. Spriet, L.; Lindinger, M.; McKelvie, R.; Heigenhauser, G.; Jones, N. Muscle glycogenolysis and H+ concentration during maximal intermittent cycling. J. Appl. Physiol. 1989, 66, 8–13. [Google Scholar] [CrossRef] [PubMed]
  70. Robergs, R.A.; Ghiasvand, F.; Parker, D. Biochemistry of exercise-induced metabolic acidosis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287, R502–R516. [Google Scholar] [CrossRef]
  71. Sahlin, K.; Harris, R.; Nylind, B.; Hultman, E. Lactate content and pH in muscle samples obtained after dynamic exercise. Pflügers Arch. 1976, 367, 143–149. [Google Scholar] [CrossRef]
  72. Böning, D.; Strobel, G.N.; Beneke, R.; Maassen, N. Lactic acid still remains the real cause of exercise-induced metabolic acidosis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R902–R903. [Google Scholar] [CrossRef]
  73. Proia, P.; Di Liegro, C.M.; Schiera, G.; Fricano, A.; Di Liegro, I. Lactate as a metabolite and a regulator in the central nervous system. Int. J. Mol. Sci. 2016, 17, 1450. [Google Scholar] [CrossRef] [PubMed]
  74. Hargreaves, M.; Spriet, L.L. Skeletal muscle energy metabolism during exercise. Nat. Metab. 2020, 2, 817–828. [Google Scholar] [CrossRef] [PubMed]
  75. Juel, C. Lactate-proton cotransport in skeletal muscle. Physiol. Rev. 1997, 77, 321–358. [Google Scholar] [CrossRef] [PubMed]
  76. Berg, J.M.; Tymoczko, J.L.; Stryer, L. Biochemistry, 5th ed.; W.H. Freeman & Co.: New York, NY, USA, 2002. [Google Scholar]
  77. Brooks, G.A. The science and translation of lactate shuttle theory. Cell Metab. 2018, 27, 757–785. [Google Scholar] [CrossRef]
  78. Robergs, R.A.; Opeyemi, O.; Torrens, S. How to be a better scientist: Lessons from scientific philosophy, the historical development of science, and past errors within exercise physiology. Sports Med. Health Sci. 2022, 4, 140–146. [Google Scholar] [CrossRef]
  79. Lindinger, M.I.; Kowalchuk, J.M.; Heigenhauser, G.J.F. Applying physicochemical principles to skeletal muscle acid-base status. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R891–R894. [Google Scholar] [CrossRef]
  80. Pesi, R.; Balestri, F.; Ipata, P.L. Anaerobic glycolysis and glycogenolysis do not release protons and do not cause acidosis. Curr. Metabolomics Syst. Biol. (Discontin.) 2020, 7, 6–10. [Google Scholar] [CrossRef]
  81. Bountra, C.; Kaila, K.; Vaughan-Jones, R.D. Effect of repetitive activity upon intracellular pH, sodium and contraction in sheep cardiac Purkinje fibres. J. Physiol. 1988, 398, 341–360. [Google Scholar] [CrossRef]
  82. DeCoursey, T.E. Voltage-gated proton channels: Molecular biology, physiology, and pathophysiology of the Hv family. Physiol. Rev. 2013, 93, 599–652. [Google Scholar] [CrossRef] [PubMed]
  83. Song, C.W.; Griffin, R.; Park, H.J. Influence of Tumor pH on Therapeutic Response. In Cancer Drug Resistance. Cancer Drug Discovery and Development; Teicher, B.A., Ed.; Humana Press: Totowa, NJ, USA, 2006. [Google Scholar]
  84. Feuvray, D. The regulation of intracellular pH in the diabetic myocardium. Cardiovasc. Res. 1997, 34, 48–54. [Google Scholar] [CrossRef] [PubMed]
  85. Allen, D.G.; Orchard, C.H. The effects of changes of pH on intracellular calcium transients in mammalian cardiac muscle. J. Physiol. 1983, 335, 555–567. [Google Scholar] [CrossRef]
  86. Senneff, S.; Lowery, M.M. Effects of extracellular potassium on calcium handling and force generation in a model of excitation-contraction coupling in skeletal muscle. J. Theor. Biol. 2021, 519, 110656. [Google Scholar] [CrossRef] [PubMed]
  87. Dulhunty, A.F. Heterogeneity of T-tubule geometry in vertebrate skeletal muscle fibres. J. Muscle Res. Cell Motil. 1984, 5, 333–347. [Google Scholar] [CrossRef] [PubMed]
  88. Sejersted, O.M.; Sjøgaard, G. Dynamics and consequences of potassium shifts in skeletal muscle and heart during exercise. Physiol. Rev. 2000, 80, 1411–1481. [Google Scholar] [CrossRef]
  89. Knuth, S.T.; Dave, H.; Peters, J.R.; Fitts, R. Low cell pH depresses peak power in rat skeletal muscle fibres at both 30 °C and 15 °C: Implications for muscle fatigue. J. Physiol. 2006, 575, 887–899. [Google Scholar] [CrossRef]
  90. Parsons, B.; Szczesna, D.; Zhao, J.; Van Slooten, G.; Kerrick, W.G.L.; Putkey, J.A.; Potter, J.D. The effect of pH on the Ca2+ affinity of the Ca2+ regulatory sites of skeletal and cardiac troponin c in skinned muscle fibres. J. Muscle Res. Cell Motil. 1997, 18, 599–609. [Google Scholar] [CrossRef]
  91. Fabiato, A.; Fabiato, F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles. J. Physiol. 1978, 276, 233–255. [Google Scholar] [CrossRef]
  92. Ball, K.L.; Johnson, M.D.; Solaro, R.J. Isoform specific interactions of troponin I and troponin C determine pH sensitivity of myofibrillar Ca2+ activation. Biochemistry 1994, 33, 8464–8471. [Google Scholar] [CrossRef] [PubMed]
  93. Metzger, J.; Moss, R. Effects of tension and stiffness due to reduced pH in mammalian fast- and slow-twitch skinned skeletal muscle fibres. J. Physiol. 1990, 428, 737–750. [Google Scholar] [CrossRef]
  94. Metzger, J.M.; Moss, R.L. pH modulation of the kinetics of a Ca2+-sensitive cross-bridge state transition in mammalian single skeletal muscle fibres. J. Physiol. 1990, 428, 751–764. [Google Scholar] [CrossRef]
  95. Metzger, J.M.; Moss, R.L. Greater hydrogen ion-induced depression of tension and velocity in skinned single fibres of rat fast than slow muscles. J. Physiol. 1987, 393, 727–742. [Google Scholar] [CrossRef]
  96. Cooke, R.; Franks, K.; Luciani, G.B.; Pate, E. The inhibition of rabbit skeletal muscle contraction by hydrogen ions and phosphate. J. Physiol. 1988, 395, 77–97. [Google Scholar] [CrossRef]
  97. Debold, E.P.; Romatowski, J.; Fitts, R.H. The depressive effect of Pi on the force-PCa relationship in skinned single muscle fibers is temperature dependent. Am. J. Physiol. Cell Physiol. 2006, 290, C1041–C1050. [Google Scholar] [CrossRef]
  98. Fitts, R.H. The cross-bridge cycle and skeletal muscle fatigue. J. Appl. Physiol. 2008, 104, 551–558. [Google Scholar] [CrossRef] [PubMed]
  99. Nosek, T.M.; Fender, K.Y.; Godt, R.E. It is diprotonated inorganic phosphate that depresses force in skinned skeletal muscle fibers. Science 1987, 236, 191–193. [Google Scholar] [CrossRef] [PubMed]
  100. Wolosker, H.; Rocha, J.B.; Engelender, S.; Panizzutti, R.; Miranda, J.D.; Meis, L.D. Sarco/endoplasmic reticulum Ca2+-ATPase isoforms: Diverse responses to acidosis. Biochem. J. 1997, 321, 545–550. [Google Scholar] [CrossRef]
  101. Allen, D.G. Skeletal muscle function: Role of ionic changes in fatigue, damage and disease. Clin. Exp. Pharmacol. Physiol. 2004, 31, 485–493. [Google Scholar] [CrossRef] [PubMed]
  102. Favero, T.G. Sarcoplasmic reticulum Ca2+ release and muscle fatigue. J. Appl. Physiol. 1999, 87, 471–483. [Google Scholar] [CrossRef]
  103. Philipson, K.D.; Bersohn, M.M.; Nishimoto, A. Effects of pH on Na+-Ca2+ exchange in canine cardiac sarcolemmal vesicles. Circ. Res. 1982, 50, 287–293. [Google Scholar] [CrossRef]
  104. Scranton, K.; John, S.; Escobar, A.; Goldhaber, J.I.; Ottolia, M. Modulation of the cardiac Na+-Ca2+ exchanger by cytoplasmic protons: Molecular mechanisms and physiological implications. Cell Calcium 2020, 87, 102140. [Google Scholar] [CrossRef]
  105. Linck, B.; Qiu, Z.; He, Z.; Tong, Q.; Hilgemann, D.W.; Philipson, K.D. Functional comparison of the three isoforms of the Na+/Ca2+ exchanger (NCX1, NCX2, NCX3). Am. J. Physiol. Cell Physiol. 1998, 274, C415–C423. [Google Scholar] [CrossRef]
  106. Donoso Laurent, P.; Hidalgo Tapia, M.C. Sodium-calcium exchange in transverse tubules isolated from frog skeletal muscle. Biochim. Biophys. Acta Biomembr. 1989, 987, 8–16. [Google Scholar] [CrossRef]
  107. Garcia, M.; Diaz, A.; Godinez, R.; Sanchez, J. Effect of sodium deprivation on contraction and charge movement in frog skeletal muscle fibres. J. Muscle Res. Cell Motil. 1992, 13, 354–365. [Google Scholar] [CrossRef]
  108. Gavriliouk, D.; Scrimgeour, N.R.; Grigoryev, S.; Ma, L.; Zhou, F.H.; Barritt, G.J.; Rychkov, G.Y. Regulation of Orai1/Stim1 mediated ICRAC by intracellular pH. Sci. Rep. 2017, 7, 9829. [Google Scholar] [CrossRef]
  109. Yu, A.S.; Yue, Z.; Feng, J.; Yue, L. Regulation of Orai/Stim channels by pH. In Calcium Entry Channels in Non-Excitable Cells, 1st ed.; Kozak, J.A., Putney, J.W., Jr., Eds.; CRC Press: Boca Raton, FL, USA, 2017; Chapter 9. [Google Scholar]
  110. Cairns, S.P.; Lindinger, M.I. Lactic acidosis: Implications for human exercise performance. Eur. J. Appl. Physiol. 2025, 125, 1761–1795. [Google Scholar] [CrossRef]
  111. Bouviere, J.; Fortunato, R.S.; Dupuy, C.; Werneck-de-Castro, J.P.; Carvalho, D.P.; Louzada, R.A. Exercise-stimulated ROS sensitive signaling pathways in skeletal muscle. Antioxidants 2021, 10, 537. [Google Scholar] [CrossRef]
  112. Drust, B.; Rasmussen, P.; Mohr, M.; Nielsen, B.; Nybo, L. Elevations in core and muscle temperature impairs repeated sprint performance. Acta Physiol. Scand. 2005, 183, 181–190. [Google Scholar] [CrossRef] [PubMed]
  113. D’Oria, R.; Schipani, R.; Leonardini, A.; Natalicchio, A.; Perrini, S.; Cignarelli, A.; Laviola, L.; Giorgino, F. The role of oxidative stress in cardiac disease: From physiological response to injury factor. Oxidative Med. Cell. Longev. 2020, 2020, 5732956. [Google Scholar] [CrossRef]
  114. Aggarwal, N.T.; Makielski, J.C. Redox control of cardiac excitability. Antioxid. Redox Signal. 2013, 18, 432–468. [Google Scholar] [CrossRef] [PubMed]
  115. Slavin, M.B.; Khemraj, P.; Hood, D.A. Exercise, mitochondrial dysfunction and inflammasomes in skeletal muscle. Biomed. J. 2024, 47, 100636. [Google Scholar] [CrossRef] [PubMed]
  116. Yan, K.; Gao, H.; Liu, X.; Zhao, Z.; Gao, B.; Zhang, L. Establishment and identification of an animal model of long-term exercise-induced fatigue. Front. Endocrinol. 2022, 13, 915937. [Google Scholar] [CrossRef]
  117. Ho, J.Q.; Abramowitz, M.K. Clinical consequences of metabolic acidosis-muscle. Adv. Chronic Kidney Dis. 2022, 29, 395–405. [Google Scholar] [CrossRef]
  118. Vaughan-Jones, R.D. Regulation of intracellular pH in cardiac muscle. In Ciba Foundation Symposium 139—Proton Passage Across Cell Membranes; Bock, G., Marsh, J., Eds.; John Wiley & Sons, Ltd.: Chichester, UK, 2007; pp. 23–46. [Google Scholar]
  119. Vandenberg, J.I.; Carter, N.D.; Bethell, H.W.; Nogradi, A.; Ridderstrale, Y.; Metcalfe, J.C.; Grace, A.A. Carbonic anhydrase and cardiac pH regulation. Am. J. Physiol. Cell Physiol. 1996, 271, C1838–C1846. [Google Scholar] [CrossRef]
  120. Orlowski, A.; Di Mattia, R.A.; Aiello, E.A. Intracellular pH regulation in ventricular myocytes: Implications for cardiac health and disease. Circ. Res. 2025, 136, 1636–1656. [Google Scholar] [CrossRef]
  121. Vaughan-Jones, R.; Eisner, D.; Lederer, W. Effects of changes of intracellular pH on contraction in sheep cardiac Purkinje fibers. J. Gen. Physiol. 1987, 89, 1015–1032. [Google Scholar] [CrossRef]
  122. Jacobus, W.E.; Pores, I.H.; Lucas, S.K.; Weisfeldt, M.L.; Flaherty, J.T. Intracellular acidosis and contractility in the normal and ischemic heart as examined by 31P NMR. J. Mol. Cell. Cardiol. 1982, 14, 13–20. [Google Scholar] [CrossRef]
  123. Choi, H.S.; Trafford, A.W.; Orchard, C.H.; Eisner, D.A. The effect of acidosis on systolic Ca2+ and sarcoplasmic reticulum calcium content in isolated rat ventricular myocytes. J. Physiol 2000, 529, 661–668. [Google Scholar] [CrossRef]
  124. Orchard, C.; Kentish, J.C. Effects of changes of pH on the contractile function of cardiac muscle. Am. J. Physiol. Cell Physiol. 1990, 258, C967–C981. [Google Scholar] [CrossRef] [PubMed]
  125. Kaibara, M.; Kameyama, M. Inhibition of the calcium channel by intracellular protons in single ventricular myocytes of the guinea pig. J. Physiol. 1988, 403, 621–640. [Google Scholar] [CrossRef] [PubMed]
  126. Balnave, C.; Vaughan-Jones, R. Effect of intracellular pH on spontaneous Ca2+ sparks in rat ventricular myocytes. J. Physiol. 2000, 528, 25–37. [Google Scholar] [CrossRef] [PubMed]
  127. Rozanski, G.J.; Witt, R.C. Acidosis masks beta-adrenergic control of cardiac L-type calcium current. J. Mol. Cell. Cardiol. 1995, 27, 1781–1788. [Google Scholar] [CrossRef]
  128. Brodde, O.-E. The functional importance of beta1 and beta2 adrenoceptors in the human heart. Am. J. Cardiol. 1988, 62, 24C–29C. [Google Scholar] [CrossRef] [PubMed]
  129. Rousseau, E.; Pinkos, J. pH modulates conducting and gating behaviour of single calcium release channels. Pflügers Arch. 1990, 415, 645–647. [Google Scholar] [CrossRef]
  130. Hulme, J.; Orchard, C. Effect of acidosis on Ca2+ uptake and release by sarcoplasmic reticulum of intact rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 1998, 275, H977–H987. [Google Scholar] [CrossRef]
  131. Fabiato, A. Use of aequorin for the appraisal of the hypothesis of the release of calcium from the sarcoplasmic reticulum induced by a change of pH in skinned cardiac cells. Cell Calcium 1985, 6, 95–108. [Google Scholar] [CrossRef]
  132. Kentish, J.C.; Xiang, J.-Z. Ca2+- and caffeine-induced Ca2+ release from the sarcoplasmic reticulum in rat skinned trabeculae: Effects of pH and Pi. Cardiovasc. Res. 1997, 33, 314–323. [Google Scholar] [CrossRef]
  133. Orchard, C. The role of the sarcoplasmic reticulum in the response of ferret and rat heart muscle to acidosis. J. Physiol. 1987, 384, 431–449. [Google Scholar] [CrossRef]
  134. Bers, D.M.; Ellis, D. Intracellular calcium and sodium activity in sheep heart Purkinje fibres: Effect of changes of external sodium and intracellular pH. Pflügers Arch. 1982, 393, 171–178. [Google Scholar] [CrossRef] [PubMed]
  135. Ellis, D.; MacLeod, K. Sodium-dependent control of intracellular pH in Purkinje fibres of sheep heart. J. Physiol. 1985, 359, 81–105. [Google Scholar] [CrossRef]
  136. Aronson, P.S.; Giebisch, G. Effects of pH on potassium: New explanations for old observations. J. Am. Soc. Nephrol. 2011, 22, 1981–1989. [Google Scholar] [CrossRef]
  137. Hilgemann, D.W.; Matsuoka, S.; Nagel, G.A.; Collins, A. Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J. Gen. Physiol. 1992, 100, 905–932. [Google Scholar] [PubMed]
  138. Scranton, K.; John, S.; Angelini, M.; Steccanella, F.; Umar, S.; Zhang, R.; Goldhaber, J.I.; Olcese, R.; Ottolia, M. Cardiac function is regulated by the sodium-dependent inhibition of the sodium-calcium exchanger NCX1. Nat. Commun. 2024, 15, 3831. [Google Scholar] [CrossRef]
  139. Doering, A.E.; Lederer, W. The action of Na+ as a cofactor in the inhibition by cytoplasmic protons of the cardiac Na+-Ca2+ exchanger in the guinea pig. J. Physiol. 1994, 480, 9–20. [Google Scholar] [CrossRef]
  140. Allen, D.G.; Xiao, X.-H. Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion. Cardiovasc. Res. 2003, 57, 934–941. [Google Scholar] [CrossRef] [PubMed]
  141. Chen, S.; Li, S. The Na+/Ca2+ exchanger in cardiac ischemia/reperfusion injury. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2012, 18, RA161. [Google Scholar] [CrossRef]
  142. Zhang, R.; Wu, X.; Kim, S.; Kim, B.; Xie, C.; Gonzalez, D.; Norris, R.; Chin, N.; Li, L.; John, S. Regulation of Na+/Ca2+ exchange by cytoplasmic protons modifies intracellular calcium dynamics and the cardiac response to ischemia. Proc. Natl. Acad. Sci. USA 2025, 122, e2423203122. [Google Scholar] [CrossRef]
  143. Gursahani, H.I.; Schaefer, S. Acidification reduces mitochondrial calcium uptake in rat cardiac mitochondria. Am. J. Physiol. Heart Circ. Physiol. 2004, 287, H2659–H2665. [Google Scholar] [CrossRef]
  144. Silverstein, T.P. The proton in biochemistry: Impacts on bioenergetics, biophysical chemistry, and bioorganic chemistry. Front. Mol. Biosci. 2021, 8, 764099. [Google Scholar] [CrossRef]
  145. Spitzer, K.W.; Ershler, P.R.; Skolnick, R.L.; Vaughan-Jones, R.D. Generation of intracellular pH gradients in single cardiac myocytes with a microperfusion system. Am. J. Physiol. Heart Circ. Physiol. 2000, 278, H1371–H1382. [Google Scholar] [CrossRef] [PubMed]
  146. Swietach, P.; Leem, C.-H.; Spitzer, K.W.; Vaughan-Jones, R.D. Experimental generation and computational modeling of intracellular pH gradients in cardiac myocytes. Biophys. J. 2005, 88, 3018–3037. [Google Scholar] [CrossRef] [PubMed]
  147. Swietach, P.; Youm, J.-B.; Saegusa, N.; Leem, C.-H.; Spitzer, K.W.; Vaughan-Jones, R.D. Coupled Ca2+/H+ transport by cytoplasmic buffers regulates local Ca2+/H+ ion signaling. Proc. Natl. Acad. Sci. USA 2013, 110, E2064–E2073. [Google Scholar] [CrossRef] [PubMed]
  148. Zaniboni, M.; Swietach, P.; Rossini, A.; Yamamoto, T.; Spitzer, K.W.; Vaughan-Jones, R.D. Intracellular proton mobility and buffering power in cardiac ventricular myocytes from rat, rabbit, and guinea pig. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H1236–H1246. [Google Scholar] [CrossRef]
  149. Kraut, J.A.; Madias, N.E. Lactic acidosis: Current treatments and future directions. Am. J. Kidney Dis. 2016, 68, 473–482. [Google Scholar] [CrossRef]
  150. Rodríguez-Villar, S.; Kraut, J.; Arévalo-Serrano, J.; Sakka, S.; Harris, C.; Awad, I.; Toolan, M.; Vanapalli, S.; Collins, A.; Spataru, A. Systemic acidemia impairs cardiac function in critically ill patients. eClinicalMedicine 2021, 37, 100956. [Google Scholar] [CrossRef]
  151. Jung, B.; Rimmele, T.; Goff, C.L.; Chanques, G.; Corne, P.; Jonquet, O.; Muller, L.; Lefrant, J.-Y.; Guervilly, C.; Papazian, L.; et al. Severe metabolic or mixed acidemia on intensive care unit admission: Incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit. Care 2011, 15, R238. [Google Scholar] [CrossRef] [PubMed]
  152. Ma, J.; Gao, X.; Li, Y.; DeCoursey, T.E.; Shull, G.E.; Wang, H.-S. The HVCN1 voltage-gated proton channel contributes to pH regulation in canine ventricular myocytes. J. Physiol. 2022, 600, 2089–2103. [Google Scholar] [CrossRef] [PubMed]
  153. Vaughan-Jones, R.D.; Spitzer, K.W. Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte. Biochem. Cell Biol. 2002, 80, 579–596. [Google Scholar] [CrossRef]
  154. Leem, C.H.; Lagadic-Gossmann, D.; Vaughan-Jones, R.D. Characterization of intracellular pH regulation in the guinea pig ventricular myocyte. J. Physiol. 1999, 517, 159–180. [Google Scholar] [CrossRef] [PubMed]
  155. Supuran, C.T. Carbonic anhydrase versatility: From pH regulation to CO2 sensing and metabolism. Front. Mol. Biosci. 2023, 10, 1326633. [Google Scholar] [CrossRef]
  156. Wang, H.-S.; Chen, Y.; Vairamani, K.; Shull, G.E. Critical role of bicarbonate and bicarbonate transporters in cardiac function. World J. Biol. Chem. 2014, 5, 334. [Google Scholar] [CrossRef]
  157. JUEL, C. Lactate/proton co-transport in skeletal muscle: Regulation and importance for pH homeostasis. Acta Physiol. Scand. 1996, 156, 369–374. [Google Scholar] [CrossRef]
  158. Geers, C.; Gros, G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol. Rev. 2000, 80, 681–715. [Google Scholar] [CrossRef]
  159. Michenkova, M.; Taki, S.; Blosser, M.C.; Hwang, H.J.; Kowatz, T.; Moss, F.J.; Occhipinti, R.; Qin, X.; Sen, S.; Shinn, E. Carbon dioxide transport across membranes. Interface Focus 2021, 11, 20200090. [Google Scholar] [CrossRef]
  160. Sahlin, K.; Alvestrand, A.; Brandt, R.; Hultman, E. Intracellular pH and bicarbonate concentration in human muscle during recovery from exercise. J. Appl. Physiol. 1978, 45, 474–480. [Google Scholar] [CrossRef]
  161. Clancy, R.; EB, B. In vivo CO2 buffer curves of skeletal and cardiac muscle. Am. J. Physiol. Leg. Content 1966, 211, 1309–1312. [Google Scholar] [CrossRef] [PubMed]
  162. Greiser, M.; Karbowski, M.; Kaplan, A.D.; Coleman, A.K.; Verhoeven, N.; Mannella, C.A.; Lederer, W.J.; Boyman, L. Calcium and bicarbonate signaling pathways have pivotal, resonating roles in matching ATP production to demand. Elife 2023, 12, e84204. [Google Scholar] [CrossRef]
  163. Torella, D.; Ellison, G.M.; Torella, M.; Vicinanza, C.; Aquila, I.; Iaconetti, C.; Scalise, M.; Marino, F.; Henning, B.J.; Lewis, F.C.; et al. Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy. J. Am. Heart Assoc. 2014, 3, e000434. [Google Scholar] [CrossRef] [PubMed]
  164. Alvarez, B.V.; Quon, A.L.; Mullen, J.; Casey, J.R. Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart. BMC Cardiovasc. Disord. 2013, 13, 2. [Google Scholar] [CrossRef]
  165. Yamamoto, T.; Shirayama, T.; Sakatani, T.; Takahashi, T.; Tanaka, H.; Takamatsu, T.; Spitzer, K.W.; Matsubara, H. Enhanced activity of ventricular Na+-HCO3 cotransport in pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H1254–H1264. [Google Scholar] [CrossRef]
  166. Djojosugito, A.M.; Folkow, B.; Lisander, B.; Sparks, H. Mechanism of escape of skeletal muscle resistance vessels from the influence of sympathetic cholinergic vasodilator fibre activity. Acta Physiol. Scand. 1968, 72, 148–156. [Google Scholar] [CrossRef] [PubMed]
  167. Wirth, K.J.; Scheibenbogen, C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med. 2021, 19, 162. [Google Scholar] [CrossRef]
  168. Iwata, Y.; Katanosaka, Y.; Hisamitsu, T.; Wakabayashi, S. Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors. Am. J. Pathol. 2007, 171, 1576–1587. [Google Scholar] [CrossRef]
  169. Wu, D.; Kraut, J.A. Role of NHE1 in the cellular dysfunction of acute metabolic acidosis. Am. J. Nephrol. 2014, 40, 36–42. [Google Scholar] [CrossRef]
  170. Heizmann, C. Parvalbumin, and intracellular calcium-binding protein; Distribution, properties and possible roles in mammalian cells. Experientia 1984, 40, 910–921. [Google Scholar] [CrossRef]
  171. Haiech, J.; Derancourt, J.; Pechere, J.F.; Demaille, J.G. Magnesium and calcium binding to parvalbumins: Evidence for differences between parvalbumins and an explanation of their relaxing function. Biochemistry 1979, 18, 2752–2758. [Google Scholar] [CrossRef] [PubMed]
  172. Eberhard, M.; Erne, P. Calcium and magnesium binding to rat parvalbumin. Eur. J. Biochem. 1994, 222, 21–26. [Google Scholar] [CrossRef] [PubMed]
  173. Chin, E.R.; Grange, R.W.; Viau, F.; Simard, A.R.; Humphries, C.; Shelton, J.; Bassel-Duby, R.; Williams, R.S.; Michel, R.N. Alterations in slow-twitch muscle phenotype in transgenic mice overexpressing the Ca2+ buffering protein parvalbumin. J. Physiol. 2003, 547, 649–663. [Google Scholar] [CrossRef] [PubMed]
  174. Vongvatcharanon, S.; Vongvatcharanon, U.; Boonyoung, P. Immunohistochemical localization of parvalbumin calcium-binding protein in the heart tissues of various species. Acta Histochem. 2008, 110, 26–33. [Google Scholar] [CrossRef] [PubMed]
  175. Heizmann, C.W.; Berchtold, M.W.; Rowlerson, A.M. Correlation of parvalbumin concentration with relaxation speed in mammalian muscles. Proc. Natl. Acad. Sci. USA 1982, 79, 7243–7247. [Google Scholar] [CrossRef]
  176. Gao, W.D.; Backx, P.H.; Azan-Backx, M.; Marban, E. Myofilament Ca2+ sensitivity in intact versus skinned rat ventricular muscle. Circ. Res. 1994, 74, 408–415. [Google Scholar] [CrossRef]
  177. Higgins, E.R.; Cannell, M.B.; Sneyd, J. A buffering SERCA pump in models of calcium dynamics. Biophys. J. 2006, 91, 151–163. [Google Scholar] [CrossRef]
  178. Smith, G.L.; Eisner, D.A. Calcium buffering in the heart in health and disease. Circulation 2019, 139, 2358–2371. [Google Scholar] [CrossRef]
  179. Cheng, Y.-R.; Chi, C.-H.; Lee, C.-H.; Lin, S.-H.; Min, M.-Y.; Chen, C.-C. Probing the effect of acidosis on tether-mode mechanotransduction of proprioceptors. Int. J. Mol. Sci. 2023, 24, 12783. [Google Scholar] [CrossRef] [PubMed]
  180. Blanchard, E.M.; Solaro, R.J. Inhibition of the activation and troponin calcium binding of dog cardiac myofibrils by acidic pH. Circ. Res. 1984, 55, 382–391. [Google Scholar] [CrossRef]
  181. Nicholls, D.G. Mitochondria and calcium signaling. Cell Calcium 2005, 38, 311–317. [Google Scholar] [CrossRef]
  182. Dedkova, E.N.; Blatter, L.A. Calcium signaling in cardiac mitochondria. J. Mol. Cell. Cardiol. 2013, 58, 125–133. [Google Scholar] [CrossRef]
  183. Gunter, K.K.; Gunter, T.E. Transport of calcium by mitochondria. J. Bioenerg. Biomembr. 1994, 26, 471–485. [Google Scholar] [CrossRef]
  184. O’Rourke, B.; Blatter, L.A. Mitochondrial Ca2+ uptake: Tortoise or hare? J. Mol. Cell. Cardiol. 2009, 46, 767–774. [Google Scholar] [CrossRef]
  185. Pallafacchina, G.; Zanin, S.; Rizzuto, R. Recent advances in the molecular mechanism of mitochondrial calcium uptake. F1000Research 2018, 7, 1858. [Google Scholar] [CrossRef] [PubMed]
  186. Glancy, B.; Balaban, R.S. Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry 2012, 51, 2959–2973. [Google Scholar] [CrossRef] [PubMed]
  187. Santo-Domingo, J.; Demaurex, N. The renaissance of mitochondrial pH. J. Gen. Physiol. 2012, 139, 415–423. [Google Scholar] [CrossRef]
  188. Wei, A.-C.; Aon, M.A.; O’Rourke, B.; Winslow, R.L.; Cortassa, S. Mitochondrial energetics, pH regulation, and ion dynamics: A computational-experimental approach. Biophys. J. 2011, 100, 2894–2903. [Google Scholar] [CrossRef]
  189. Zotova, L.; Aleschko, M.; Sponder, G.; Baumgartner, R.; Reipert, S.; Prinz, M.; Schweyen, R.J.; Nowikovsky, K. Novel components of an active mitochondrial K+/H+ exchange. J. Biol. Chem. 2010, 285, 14399–14414. [Google Scholar] [CrossRef]
  190. Jiang, D.; Zhao, L.; Clapham, D.E. Genome-wide RNAi screen identifies LETM1 as a mitochondrial Ca2+/H+ antiporter. Science 2009, 326, 144–147. [Google Scholar] [CrossRef]
  191. Lyu, Y.; Thai, P.N.; Ren, L.; Timofeyev, V.; Jian, Z.; Park, S.; Ginsburg, K.S.; Overton, J.; Bossuyt, J.; Bers, D.M.; et al. Beat-to-beat dynamic regulation of intracellular pH in cardiomyocytes. iScience 2022, 25, 103624. [Google Scholar] [CrossRef]
  192. Abou Sawan, S.; Mazzulla, M.; Moore, D.R.; Hodson, N. More than just a garbage can: Emerging roles of the lysosome as an anabolic organelle in skeletal muscle. Am. J. Physiology. Cell Physiol. 2020, 319, C561–C568. [Google Scholar] [CrossRef] [PubMed]
  193. Terman, A.; Kurz, T.; Gustafsson, B.; Brunk, U.T. The involvement of lysosomes in myocardial aging and disease. Curr. Cardiol. Rev. 2008, 4, 107–115. [Google Scholar] [CrossRef] [PubMed]
  194. Bootman, M.D.; Bultynck, G. Fundamentals of cellular calcium signaling: A primer. Cold Spring Harb. Perspect. Biol. 2020, 12, a038802. [Google Scholar] [CrossRef] [PubMed]
  195. Mellman, I.; Fuchs, R.; Helenius, A. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 1986, 55, 663–700. [Google Scholar] [CrossRef]
  196. Settembre, C.; Fraldi, A.; Medina, D.L.; Ballabio, A. Signals from the lysosome: A control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 2013, 14, 283–296. [Google Scholar] [CrossRef]
  197. Raffaello, A.; Mammucari, C.; Gherardi, G.; Rizzuto, R. Calcium at the center of cell signaling: Interplay between endoplasmic reticulum, mitochondria, and lysosomes. Trends Biochem. Sci. 2016, 41, 1035–1049. [Google Scholar] [CrossRef]
  198. Breton, S.; Brown, D. Regulation of luminal acidification by the V-ATPase. Physiology 2013, 28, 318–329. [Google Scholar] [CrossRef]
  199. Mindell, J.A. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 2012, 74, 69–86. [Google Scholar] [CrossRef]
  200. Xiong, J.; Zhu, M.X. Regulation of lysosomal ion homeostasis by channels and transporters. Sci. China Life Sci. 2016, 59, 777–791. [Google Scholar] [CrossRef] [PubMed]
  201. Galione, A. A primer of NAADP-mediated Ca2+ signalling: From sea urchin eggs to mammalian cells. Cell Calcium 2015, 58, 27–47. [Google Scholar] [CrossRef]
  202. Capel, R.A.; Bolton, E.L.; Lin, W.K.; Aston, D.; Wang, Y.; Liu, W.; Wang, X.; Burton, R.-A.B.; Bloor-Young, D.; Shade, K.-T. Two-pore channels (TPC2s) and nicotinic acid adenine dinucleotide phosphate (NAADP) at lysosomal-sarcoplasmic reticular junctions contribute to acute and chronic β-adrenoceptor signaling in the heart. J. Biol. Chem. 2015, 290, 30087–30098. [Google Scholar] [CrossRef]
  203. Serano, M.; Perni, S.; Pierantozzi, E.; Laurino, A.; Sorrentino, V.; Rossi, D. Intracellular membrane contact sites in skeletal muscle cells. Membranes 2025, 15, 29. [Google Scholar] [CrossRef]
  204. Espinoza-Fonseca, L.M. The Ca2+-ATPase pump facilitates bidirectional proton transport across the sarco/endoplasmic reticulum. Mol. Biosyst. 2017, 13, 633–637. [Google Scholar] [CrossRef] [PubMed]
  205. Zhou, X.; Belavek, K.J.; Miller, E.W. Origins of Ca2+ imaging with fluorescent indicators. Biochemistry 2021, 60, 3547–3554. [Google Scholar] [CrossRef]
  206. Takahashi, A.; Camacho, P.; Lechleiter, J.D.; Herman, B. Measurement of intracellular calcium. Physiol. Rev. 1999, 79, 1089–1125. [Google Scholar] [CrossRef]
  207. Tsien, R.Y. New calcium indicators and buffers with high selectivity against magnesium and protons: Design, synthesis, and properties of prototype structures. Biochemistry 1980, 19, 2396–2404. [Google Scholar] [CrossRef] [PubMed]
  208. Paredes, R.M.; Etzler, J.C.; Watts, L.T.; Zheng, W.; Lechleiter, J.D. Chemical calcium indicators. Methods 2008, 46, 143–151. [Google Scholar] [CrossRef] [PubMed]
  209. Wu, J.; Prole, D.L.; Shen, Y.; Lin, Z.; Gnanasekaran, A.; Liu, Y.; Chen, L.; Zhou, H.; Chen, S.W.; Usachev, Y.M. Red fluorescent genetically encoded Ca2+ indicators for use in mitochondria and endoplasmic reticulum. Biochem. J. 2014, 464, 13–22. [Google Scholar] [CrossRef]
  210. Carlson, H.J.; Campbell, R.E. Circular permutated red fluorescent proteins and calcium ion indicators based on mCherry. Protein Eng. Des. Sel. 2013, 26, 763–772. [Google Scholar] [CrossRef]
  211. Zhao, Y.; Araki, S.; Wu, J.; Teramoto, T.; Chang, Y.-F.; Nakano, M.; Abdelfattah, A.S.; Fujiwara, M.; Ishihara, T.; Nagai, T.; et al. An expanded palette of genetically encoded Ca2+ indicators. Science 2011, 333, 1888–1891. [Google Scholar] [CrossRef]
  212. Davis, L.C.; Morgan, A.J.; Galione, A. NAADP-regulated two-pore channels drive phagocytosis through endo- and lysosomal Ca2+ nanodomains, calcineurin and dynamin. EMBO J. 2020, 39, e104058. [Google Scholar] [CrossRef] [PubMed]
  213. Patterson, G.H.; Knobel, S.M.; Sharif, W.D.; Kain, S.R.; Piston, D.W. Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy. Biophys. J. 1997, 73, 2782–2790. [Google Scholar] [CrossRef]
  214. Li, S.-A.; Meng, X.-Y.; Zhang, Y.-J.; Chen, C.-L.; Jiao, Y.-X.; Zhu, Y.-Q.; Liu, P.-P.; Sun, W. Progress in pH-sensitive sensors: Essential tools for organelle pH detection, spotlighting mitochondrion and diverse applications. Front. Pharmacol. 2024, 14, 1339518. [Google Scholar] [CrossRef] [PubMed]
  215. Albrecht, T.; Zhao, Y.; Nguyen, T.H.; Campbell, R.E.; Johnson, J.D. Fluorescent biosensors illuminate calcium levels within defined beta-cell endosome subpopulations. Cell Calcium 2015, 57, 263–274. [Google Scholar] [CrossRef]
  216. Mank, M.; Griesbeck, O. Genetically encoded calcium indicators. Chem. Rev. 2008, 108, 1550–1564. [Google Scholar] [CrossRef]
  217. Llopis, J.; McCaffery, J.M.; Miyawaki, A.; Farquhar, M.G.; Tsien, R.Y. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl. Acad. Sci. USA 1998, 95, 6803–6808. [Google Scholar] [CrossRef]
  218. Han, J.; Burgess, K. Fluorescent indicators for intracellular pH. Chem. Rev. 2010, 110, 2709–2728. [Google Scholar] [CrossRef]
  219. Martinez-Zaguilan, R.; Tompkins, L.S.; Gillies, R.J.; Lynch, R.M. Simultaneous analysis of intracellular pH and Ca2+ from cell populations. In Calcium Signaling Protocols; Lambert, D., Rainbow, R., Eds.; Humana Press: Totowa, NJ, USA, 2013; Volume 937, pp. 253–271. [Google Scholar]
  220. Austin, C.; Dilly, K.; Eisner, D.; Wray, S. Simultaneous measurement of intracellular pH, calcium, and tension in rat mesenteric vessels: Effects of extracellular pH. Biochem. Biophys. Res. Commun. 1996, 222, 537–540. [Google Scholar] [CrossRef]
  221. Westerblad, H. Acidosis is not a significant cause of skeletal muscle fatigue. Med. Sci. Sports Exerc. 2016, 48, 2339–2342. [Google Scholar] [CrossRef] [PubMed]
  222. Stackhouse, S.K.; Reisman, D.S.; Binder-Macleod, S.A. Challenging the role of pH in skeletal muscle fatigue. Phys. Ther. 2001, 81, 1897–1903. [Google Scholar] [CrossRef] [PubMed]
  223. Han, S.-W.; Kolb, J.; Farman, G.P.; Gohlke, J.; Granzier, H.L. Glycerol storage increases passive stiffness of muscle fibers through effects on titin extensibility. J. Gen. Physiol. 2025, 157, e202413729. [Google Scholar] [CrossRef]
  224. Ranatunga, K. Effects of acidosis on tension development in mammalian skeletal muscle. Muscle Nerve Off. J. Am. Assoc. Electrodiagn. Med. 1987, 10, 439–445. [Google Scholar] [CrossRef]
  225. Bernheim, L.; Krause, R.M.; Baroffio, A.; Hamann, M.; Kaelin, A.; Bader, C.R. A voltage-dependent proton current in cultured human skeletal muscle myotubes. J. Physiol. 1993, 470, 313–333. [Google Scholar] [CrossRef]
  226. Krause, R.M.; Bernheim, L.; Bader, C.R. Human skeletal muscle has a voltage-gated proton current. Neuromuscul. Disord. NMD 1993, 3, 407–411. [Google Scholar] [CrossRef] [PubMed]
  227. Vairamani, K.; Wang, H.-S.; Medvedovic, M.; Lorenz, J.N.; Shull, G.E. RNAseq analysis indicates that the AE3 Cl/HCO3 exchanger contributes to active transport-mediated CO2 disposal in heart. Sci. Rep. 2017, 7, 7264. [Google Scholar] [CrossRef] [PubMed]
  228. Bkaily, G.; Jacques, D. Na+–H+ exchanger and proton channel in heart failure associated with Becker and Duchenne muscular dystrophies. Can. J. Physiol. Pharmacol. 2017, 95, 1213–1223. [Google Scholar] [CrossRef]
  229. Wakabayashi, S.; Hisamitsu, T.; Nakamura, T.Y. Regulation of the cardiac Na+/H+ exchanger in health and disease. J. Mol. Cell. Cardiol. 2013, 61, 68–76. [Google Scholar] [CrossRef]
  230. Swietach, P.; Despa, S. Channelling protons out of the heart. J. Physiol. 2022, 600, 2551–2552. [Google Scholar] [CrossRef] [PubMed]
  231. Decoursey, T.E. Voltage-gated proton channels and other proton transfer pathways. Physiol. Rev. 2003, 83, 475–579. [Google Scholar] [CrossRef]
  232. Cherny, V.V.; Markin, V.S.; DeCoursey, T.E. The voltage-activated hydrogen ion conductance in rat alveolar epithelial cells is determined by the pH gradient. J. Gen. Physiol. 1995, 105, 861–896. [Google Scholar] [CrossRef] [PubMed]
  233. Chaves, G.; Jardin, C.; Derst, C.; Musset, B. Voltage-gated proton channels in the tree of life. Biomolecules 2023, 13, 1035. [Google Scholar] [CrossRef]
  234. Musset, B.; Smith, S.M.; Rajan, S.; Morgan, D.; Cherny, V.V.; DeCoursey, T.E. Aspartate 112 is the selectivity filter of the human voltage-gated proton channel. Nature 2011, 480, 273–277. [Google Scholar] [CrossRef]
  235. Meech, R.; Thomas, R. Effect of measured calcium chloride injections on the membrane potential and internal pH of snail neurones. J. Physiol. 1980, 298, 111–129. [Google Scholar] [CrossRef]
  236. Hu, Y.-L.; Mi, X.; Huang, C.; Wang, H.-F.; Song, J.-R.; Shu, Q.; Ni, L.; Chen, J.-G.; Wang, F.; Hu, Z.-L. Multiple H+ sensors mediate the extracellular acidification-induced [Ca2+]i elevation in cultured rat ventricular cardiomyocytes. Sci. Rep. 2017, 7, 44951. [Google Scholar] [CrossRef]
  237. Sisignano, M.; Fischer, M.J.M.; Geisslinger, G. Proton-sensing GPCRs in health and disease. Cells 2021, 10, 2050. [Google Scholar] [CrossRef]
  238. Jaimovich, E.; Carrasco, M.A. Ip3 dependent Ca2+ signals in muscle cells are involved in regulation of gene expression. Biol. Res. 2002, 35, 195–202. [Google Scholar] [CrossRef] [PubMed]
  239. Bers, D.M. Ca2+-calmodulin-dependent protein kinase II regulation of cardiac excitation-transcription coupling. Heart Rhythm. 2011, 8, 1101–1104. [Google Scholar] [CrossRef] [PubMed]
  240. Jean-Baptiste, G.; Yang, Z.; Khoury, C.; Gaudio, S.; Greenwood, M.T. Peptide and non-peptide G-protein coupled receptors (GPCRs) in skeletal muscle. Peptides 2005, 26, 1528–1536. [Google Scholar] [CrossRef] [PubMed]
  241. Russell, J.L.; Goetsch, S.C.; Aguilar, H.R.; Coe, H.; Luo, X.; Liu, N.; van Rooij, E.; Frantz, D.E.; Schneider, J.W. Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. ACS Chem. Biol. 2012, 7, 1077–1083. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Excitation–contraction coupling in striated muscle cells. (1) Membrane depolarization generates an action potential (AP) that propagates into T-tubules. (2) Depolarization is sensed by voltage-sensing proteins DHPR (skeletal muscle cells, box 1, 2a) or LTCC (cardiac cells, box 1, 2b). (3) This opens Ca-release channels (RyRs) at the sarcoplasmic reticulum, which causes a large elevation of [Ca2+]CYT. (4) Ca2+ release activates the contractile proteins of the sarcomere to initiate muscle contraction. Box 2 shows a snapshot of the cross-bridge cycle, the Ca2+-dependent interaction of actin and myosin. The muscle cell relaxes when resting Ca2+ levels are restored. (5) This is mediated by transporting Ca2+ ions into the SR by SERCA and (6) by transporting Ca2+ out of the cell via NCX. (7) NCX uses the Na+ gradient across the plasma membrane for its transport, which is provided by the Na+/K+-ATPase. (8) Ca2+-uptake into mitochondria may buffer elevations in [Ca2+]CYT in cardiac myocytes. (9) Ca2+ influx via SOCE supports refilling of the SR by SERCA in skeletal muscle cells. DHPR: dihydropyridine receptor. LTCC: L-type Ca2+ channel. mU: mitochondrial calcium uniporter. NCX: Na+/Ca2+-exchanger. SERCA: sarcoplasmic/endoplasmic Ca2+ ATPase. SOCE: store-operated Ca2+ entry. VGSC: voltage-gated sodium channel.
Figure 1. Excitation–contraction coupling in striated muscle cells. (1) Membrane depolarization generates an action potential (AP) that propagates into T-tubules. (2) Depolarization is sensed by voltage-sensing proteins DHPR (skeletal muscle cells, box 1, 2a) or LTCC (cardiac cells, box 1, 2b). (3) This opens Ca-release channels (RyRs) at the sarcoplasmic reticulum, which causes a large elevation of [Ca2+]CYT. (4) Ca2+ release activates the contractile proteins of the sarcomere to initiate muscle contraction. Box 2 shows a snapshot of the cross-bridge cycle, the Ca2+-dependent interaction of actin and myosin. The muscle cell relaxes when resting Ca2+ levels are restored. (5) This is mediated by transporting Ca2+ ions into the SR by SERCA and (6) by transporting Ca2+ out of the cell via NCX. (7) NCX uses the Na+ gradient across the plasma membrane for its transport, which is provided by the Na+/K+-ATPase. (8) Ca2+-uptake into mitochondria may buffer elevations in [Ca2+]CYT in cardiac myocytes. (9) Ca2+ influx via SOCE supports refilling of the SR by SERCA in skeletal muscle cells. DHPR: dihydropyridine receptor. LTCC: L-type Ca2+ channel. mU: mitochondrial calcium uniporter. NCX: Na+/Ca2+-exchanger. SERCA: sarcoplasmic/endoplasmic Ca2+ ATPase. SOCE: store-operated Ca2+ entry. VGSC: voltage-gated sodium channel.
Biomolecules 15 01244 g001
Figure 2. Effects of intracellular protons on Ca2+ release and contractility in striated muscle cells. An increase in [H+]CYT has multiple effects on Ca2+ handling proteins: (1) Inhibition of RyRs reduces the amount of Ca2+ to be released from the SR. (2) Protonation of troponin C reduces its affinity for Ca2+. In addition, protonation of myosin slows down ATP hydrolysis at myosin heads and, thus, performance of the cross-bridge cycle. (3) Accumulation of inorganic phosphate Pi and ADP at myosin heads impairs repetitive cross-bridge formation, an effect that is additive to protonation of myosin. (4) Inhibition of SERCA reduces SR Ca2+ content. (5) Inhibition of NCX causes accumulation of Ca2+ in the cytosol (cardiac cells). (6) Protons inhibit the Na+/K+-ATPase, which causes intracellular Na+ accumulation and reduces the gradient for Na+ across the plasma membrane. This may further limit the transport rate of NCX in direct mode. (7) Protonation inhibits SOCE, which impairs refilling of the SR in skeletal muscle cells. (8) Protons can enter mitochondria via mitochondrial transporters (mT). Acidification of the mitochondrial matrix impairs mitochondrial Ca2+ uptake via the uniporter, which may contribute to the observed increase in [Ca2+]CYT during acidosis (cardiac myocytes). 9 to 14: Cellular proton handling mechanisms: (9) Membrane depolarization opens the voltage-gated proton channel Hv1 during the cardiac action potential. (10) Protons leave the cell via extrusion by the monocarboxylate transporter (MCT) in symport with lactate and by the sodium–proton exchanger (NHE, 11). Strong activation of NHE adds to the intracellular Na+ accumulation. 12 to 14: Long-term regulation of pH by the CO2/bicarbonate (HCO3-) buffer system. Bicarbonate can enter the cell via the sodium/bicarbonate cotransporter (NBC, 12) and can be excluded from the cell via Cl/bicarbonate anion exchange (AE, 13). Additionally, bicarbonate is formed by intracellular carbonic anhydrases (CAs) that metabolize CO2 stemming from mitochondrial respiration (not shown in Figure 2). (14) CAs catalyze the reaction of protons with bicarbonate, which yields H2O and CO2. The latter leaves the cell by diffusion. Extracellular CA catalyzes the hydration of CO2, which provides bicarbonate for NBC and AE transporters and releases protons into the extracellular space.
Figure 2. Effects of intracellular protons on Ca2+ release and contractility in striated muscle cells. An increase in [H+]CYT has multiple effects on Ca2+ handling proteins: (1) Inhibition of RyRs reduces the amount of Ca2+ to be released from the SR. (2) Protonation of troponin C reduces its affinity for Ca2+. In addition, protonation of myosin slows down ATP hydrolysis at myosin heads and, thus, performance of the cross-bridge cycle. (3) Accumulation of inorganic phosphate Pi and ADP at myosin heads impairs repetitive cross-bridge formation, an effect that is additive to protonation of myosin. (4) Inhibition of SERCA reduces SR Ca2+ content. (5) Inhibition of NCX causes accumulation of Ca2+ in the cytosol (cardiac cells). (6) Protons inhibit the Na+/K+-ATPase, which causes intracellular Na+ accumulation and reduces the gradient for Na+ across the plasma membrane. This may further limit the transport rate of NCX in direct mode. (7) Protonation inhibits SOCE, which impairs refilling of the SR in skeletal muscle cells. (8) Protons can enter mitochondria via mitochondrial transporters (mT). Acidification of the mitochondrial matrix impairs mitochondrial Ca2+ uptake via the uniporter, which may contribute to the observed increase in [Ca2+]CYT during acidosis (cardiac myocytes). 9 to 14: Cellular proton handling mechanisms: (9) Membrane depolarization opens the voltage-gated proton channel Hv1 during the cardiac action potential. (10) Protons leave the cell via extrusion by the monocarboxylate transporter (MCT) in symport with lactate and by the sodium–proton exchanger (NHE, 11). Strong activation of NHE adds to the intracellular Na+ accumulation. 12 to 14: Long-term regulation of pH by the CO2/bicarbonate (HCO3-) buffer system. Bicarbonate can enter the cell via the sodium/bicarbonate cotransporter (NBC, 12) and can be excluded from the cell via Cl/bicarbonate anion exchange (AE, 13). Additionally, bicarbonate is formed by intracellular carbonic anhydrases (CAs) that metabolize CO2 stemming from mitochondrial respiration (not shown in Figure 2). (14) CAs catalyze the reaction of protons with bicarbonate, which yields H2O and CO2. The latter leaves the cell by diffusion. Extracellular CA catalyzes the hydration of CO2, which provides bicarbonate for NBC and AE transporters and releases protons into the extracellular space.
Biomolecules 15 01244 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pluteanu, F.; Musset, B.; Rinne, A. Ca2+ Signaling in Striated Muscle Cells During Intracellular Acidosis. Biomolecules 2025, 15, 1244. https://doi.org/10.3390/biom15091244

AMA Style

Pluteanu F, Musset B, Rinne A. Ca2+ Signaling in Striated Muscle Cells During Intracellular Acidosis. Biomolecules. 2025; 15(9):1244. https://doi.org/10.3390/biom15091244

Chicago/Turabian Style

Pluteanu, Florentina, Boris Musset, and Andreas Rinne. 2025. "Ca2+ Signaling in Striated Muscle Cells During Intracellular Acidosis" Biomolecules 15, no. 9: 1244. https://doi.org/10.3390/biom15091244

APA Style

Pluteanu, F., Musset, B., & Rinne, A. (2025). Ca2+ Signaling in Striated Muscle Cells During Intracellular Acidosis. Biomolecules, 15(9), 1244. https://doi.org/10.3390/biom15091244

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop